| 1 | ( L ) ASCORBATO DI CALCIO | [1]  Calcium Calcium | - | - | - | [2]  96 96, 97 💬
 | 
| 2 | (-)-3-(4-Aminophenyl)-2-methoxypropionic acid | - | - | - | - | [1]  97 97 💬
 | 
| 3 | (R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid | [2]  Butyric Acid Butyric Acid, Chloride ion | - | - | - | [1]  97 97 💬
 | 
| 4 | (S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid | - | - | - | - | [1]  97 97 💬
 | 
| 5 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride | - | - | - | - | [1]  97 97 💬
 | 
| 6 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben | - | - | - | - | [1]  97 97 💬
 | 
| 7 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride | - | - | - | - | [1]  97 97 💬
 | 
| 8 | * D.3.4 Solution for infusion in pre-filled syringe | - | - | - | - | [1]  97 97 💬
 | 
| 9 | * D.3.4 Solution for injection in pre-filled syringe | - | - | - | - | [1]  97 97 💬
 | 
| 10 | * D.3.4 Solution for injection/infusion in pre-filled syringe | - | - | - | - | [1]  97 97 💬
 | 
| 11 | -aminosalicylic acid | [1]  Aminosalicylic acid Aminosalicylic acid | [1]  Aminosalicylic acid 
                
                    Aminosalicylic acid
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 12 | 0.25 mg RPC103 | - | - | - | - | [1]  97 97 💬
 | 
| 13 | 0.25 mg RPC1063 | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 14 | 0.25mg RPC103 | - | - | - | - | [1]  97 97 💬
 | 
| 15 | 0.25mg RPC1063 | - | - | - | - | [2]  13 13, 97 💬
 | 
| 16 | 0.5 mg RPC1063 | - | - | - | - | [2]  13 13, 97 💬
 | 
| 17 | 1 mg RPC1063 | - | - | - | - | [2]  13 13, 97 💬
 | 
| 18 | 1 Serving of broccoli sprouts | [1]  Broccoli Broccoli | - | - | - | [1]  97 97 💬
 | 
| 19 | 1.0 mg RPC103 | - | - | - | - | [1]  97 97 💬
 | 
| 20 | 1.0 mg RPC1063 | - | - | - | - | [1]  97 97 💬
 | 
| 21 | 1.Remicade | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 22 | 10 mg Natura-alpha capsule | - | - | - | - | [1]  97 97 💬
 | 
| 23 | 100 | - | - | - | - | [2]  6 6, 97 💬
 | 
| 24 | 100 mg | - | - | - | - | [1]  97 97 💬
 | 
| 25 | 14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 26 | 150 mg Induction/Chronic | - | - | - | - | [1]  97 97 💬
 | 
| 27 | 1500mg mesalazine pellets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 28 | 15N2-tofacitinib | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 29 | 2 x 10 mg Natura-alpha capsules | - | - | - | - | [1]  97 97 💬
 | 
| 30 | 2'-Fucosyllactose | - | - | - | - | [2]  96 96, 97 💬
 | 
| 31 | 2-Hydroxybenzoic acid | [1]  Salicylic acid Salicylic acid | [1]  Salicylic acid 
                
                    Salicylic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 32 | 20 mg | - | - | - | - | [1]  97 97 💬
 | 
| 33 | 225mg SHP647 (PF-00547659) | - | - | - | - | [1]  97 97 💬
 | 
| 34 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | [2]  96 96, 97 💬
 | 
| 35 | 25 mg Ontamalimab | [1]  Ontamalimab Ontamalimab | - | - | - | [2]  96 96, 97 💬
 | 
| 36 | 250mg mesalazine pellets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 37 | 2L polyethylene glycol/ascorbic acid | [2]  Ascorbic acid Ascorbic acid, Polyethylene glycol | [2]  Ascorbic acid 
                
                    Ascorbic acid
                
            , 
                
                    Polyethylene glycol 3350
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 38 | 3 Servings of broccoli sprouts | [1]  Broccoli Broccoli | - | - | - | [1]  97 97 💬
 | 
| 39 | 3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III) | [1]  Tromethamine Tromethamine | [1]  Tromethamine 
                
                    Tromethamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 40 | 331731-18-1 | - | - | - | - | [4]  46 46, 96, 97, 271 💬
 | 
| 41 | 40 mg MSB11022 | - | - | - | - | [5]  46 46, 96, 97, 107, 271 💬
 | 
| 42 | 42942019 | - | - | - | - | [4]  46 46, 96, 97, 271 💬
 | 
| 43 | 450 mg Induction/Chronic | - | - | - | - | [1]  97 97 💬
 | 
| 44 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | [1]  97 97 💬
 | 
| 45 | 5-amino salicylic acid | [1]  Salicylic acid Salicylic acid | [1]  Salicylic acid 
                
                    Salicylic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 46 | 5-amino salicylic acid (5-ASA) | [2]  Mesalazine Mesalazine, Salicylic acid | [2]  Salicylic acid 
                
                    Salicylic acid
                
            , 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 47 | 5-amino-2-hydroxybenzoic acid | [1]  Salicylic acid Salicylic acid | [1]  Salicylic acid 
                
                    Salicylic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 48 | 5-Aminosalicyclic acid | - | - | - | - | [1]  97 97 💬
 | 
| 49 | 5-aminosalicylate (Pentasa, Ferring) | - | - | - | - | [2]  96 96, 97 💬
 | 
| 50 | 5-Aminosalicylic acid | [2]  Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2]  Aminosalicylic acid 
                
                    Aminosalicylic acid
                
            , 
                
                    Mesalamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 51 | 5-Aminosalicylic acid (5-ASA) | [2]  Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2]  Aminosalicylic acid 
                
                    Aminosalicylic acid
                
            , 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 52 | 5-ASA | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 53 | 5-ASA (5-Aminosalicylate) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 54 | 5-ASA MMx | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 55 | 5-HTP | - | - | - | - | [2]  96 96, 97 💬
 | 
| 56 | 50 mg | - | - | - | - | [1]  97 97 💬
 | 
| 57 | 50 mg Induction/Chronic | - | - | - | - | [1]  97 97 💬
 | 
| 58 | 500mg mesalazine pellets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 59 | 549-0261/F02-01 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 60 | 6 Mercaptopurine | [1]  Mercaptopurine Mercaptopurine | [2]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [2]  96 96, 97 💬
 | 
| 61 | 6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid | - | - | - | - | [1]  97 97 💬
 | 
| 62 | 6-Mercaptopurine | [1]  Mercaptopurine Mercaptopurine | [2]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [3]  96 96, 97, 164 💬
 | 
| 63 | 6-MP | [1]  Mercaptopurine Mercaptopurine | [2]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [2]  96 96, 97 💬
 | 
| 64 | 75 mg Ontamalimab | [1]  Ontamalimab Ontamalimab | - | - | - | [2]  96 96, 97 💬
 | 
| 65 | 750mg mesalazine pellets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 66 | 75mg SHP647 (PF-00547659) | - | - | - | - | [1]  97 97 💬
 | 
| 67 | 90 mg hydrocortisone acetate suppository with Sephure suppository applicator | [3]  Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | [2]  Hydrocortisone 
                
                    Hydrocortisone
                
            , 
                
                    Hydrocortisone acetate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 68 | 90 mg idrocortisone acetato in supposta con appli | - | - | - | - | [1]  97 97 💬
 | 
| 69 | 90 mg idrocortisone acetato in supposta con applicatore per supposte Sephure | - | - | - | - | [1]  97 97 💬
 | 
| 70 | [124I]IB PF 06687234 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 71 | [18F]FSPG | - | - | - | - | [2]  96 96, 97 💬
 | 
| 72 | A multistrain probiotic product (DSF) | - | - | - | - | [1]  97 97 💬
 | 
| 73 | A07DA03 | - | - | - | - | [1]  97 97 💬
 | 
| 74 | A: 1 dosis | - | - | - | - | [1]  97 97 💬
 | 
| 75 | AB (antibiotics) | - | - | - | - | [1]  97 97 💬
 | 
| 76 | Abalimumab | - | - | - | - | [1]  97 97 💬
 | 
| 77 | Abatacept | [1]  Abatacept Abatacept | [1]  Abatacept 
                
                    Abatacept
                
             💬
 | [2]  CD80 CD80, CD86 💬
 | [13]  Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [26]  11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 78 | Abatacept (ABA) | [1]  Abatacept Abatacept | [1]  Abatacept 
                
                    Abatacept
                
             💬
 | [2]  CD80 CD80, CD86 💬
 | [13]  Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1]  97 97 💬
 | 
| 79 | ABBV-006 | - | - | - | - | [1]  97 97 💬
 | 
| 80 | ABBV-066 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 81 | ABBV-323 | - | - | - | - | [2]  53 53, 97 💬
 | 
| 82 | ABBV-323 Dose A | - | - | - | - | [1]  97 97 💬
 | 
| 83 | ABBV-323 Dose B | - | - | - | - | [1]  97 97 💬
 | 
| 84 | ABBV-668 | - | - | - | - | [1]  97 97 💬
 | 
| 85 | AbGn-168H | - | - | - | - | [1]  97 97 💬
 | 
| 86 | ABI-M201 | - | - | - | - | [1]  97 97 💬
 | 
| 87 | Abrilumab | [1]  Abrilumab Abrilumab | [1]  Abrilumab 
                
                    Abrilumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 88 | ABT-494 | - | - | - | - | [7]  41 41, 46, 49, 96, 97, 107, 271 💬
 | 
| 89 | ABT-Humira | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 97 💬
 | 
| 90 | ABX464 | - | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 91 | ABX464 100mg | - | - | - | - | [2]  46 46, 97 💬
 | 
| 92 | ABX464 25mg | - | - | - | - | [1]  97 97 💬
 | 
| 93 | ABX464 50mg | - | - | - | - | [2]  46 46, 97 💬
 | 
| 94 | Accelerated 1 hour-infusion | - | - | - | - | [2]  96 96, 97 💬
 | 
| 95 | Accelerated 30 minutes-infusion | - | - | - | - | [2]  96 96, 97 💬
 | 
| 96 | Acetate | [1]  Acetate Acetate | - | - | - | [41]  1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
 | 
| 97 | ACETATO DI AMMONIO | - | - | - | - | [1]  97 97 💬
 | 
| 98 | Acetic acid | [1]  Acetic acid Acetic acid | [1]  Acetic acid, glacial 
                
                    Acetic acid, glacial
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 99 | Acidophilus | [1]  Lactobacillus acidophilus Lactobacillus acidophilus | [1]  Lactomin 
                
                    Lactomin
                
             💬
 | - | - | [2]  6 6, 97 💬
 | 
| 100 | Adalimumab | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [17]  19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
 | 
| 101 | Adalimumab 40mg | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 102 | Adipate | [1]  Iron (III) oxide adipate Iron (III) oxide adipate | - | - | - | [2]  97 97, 228 💬
 | 
| 103 | Adipose derived, autologous mesenchymal stem cells | - | - | - | - | [1]  97 97 💬
 | 
| 104 | Adipose tissue-derived mesenchymal stem cells | - | - | - | - | [1]  97 97 💬
 | 
| 105 | Adipose-cord mesenchymal stromal cells (A-MSCs) | [1]  Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1]  97 97 💬
 | 
| 106 | AEB071 | - | - | - | - | [1]  97 97 💬
 | 
| 107 | AEB071A | - | - | - | - | [1]  97 97 💬
 | 
| 108 | AG011 | - | - | - | - | [1]  97 97 💬
 | 
| 109 | AG011 - Capsules | - | - | - | - | [1]  97 97 💬
 | 
| 110 | AG011 - Enema | - | - | - | - | [1]  97 97 💬
 | 
| 111 | Air | - | - | - | - | [3]  85 85, 97, 193 💬
 | 
| 112 | AJG501 | - | - | - | - | [1]  97 97 💬
 | 
| 113 | AJG511 | - | - | - | - | [1]  97 97 💬
 | 
| 114 | AJM300 | - | - | - | - | [1]  97 97 💬
 | 
| 115 | AL | - | - | - | - | [11]  5 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 💬
 | 
| 116 | ALDESLEUKIN | [1]  Aldesleukin Aldesleukin | [1]  Aldesleukin 
                
                    Aldesleukin
                
             💬
 | [3]  IL2RA IL2RA, IL2RB, IL2RG 💬
 | [14]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [4]  49 49, 65, 96, 97 💬
 | 
| 117 | Algin | [1]  Alginic acid Alginic acid | [1]  Alginic acid 
                
                    Alginic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 118 | Alicaforsen | [1]  Alicaforsen Alicaforsen | - | - | - | [2]  96 96, 97 💬
 | 
| 119 | Alkaline Phosphatase | [1]  Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [4]  46 46, 93, 97, 172 💬
 | 
| 120 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | [1]  97 97 💬
 | 
| 121 | Allopurinol | [1]  Allopurinol Allopurinol | [1]  Allopurinol 
                
                    Allopurinol
                
             💬
 | [1]  XDH XDH 💬
 | [6]  Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | [7]  6 6, 46, 57, 60, 66, 96, 97 💬
 | 
| 122 | AloASC | - | - | - | - | [1]  97 97 💬
 | 
| 123 | Aloe | [1]  Aloe vera leaf Aloe vera leaf | - | - | - | [2]  97 97, 226 💬
 | 
| 124 | Aloe Barbadensis Miller | [1]  Aloe vera leaf Aloe vera leaf | - | - | - | [1]  97 97 💬
 | 
| 125 | Aloe vera | [1]  Aloe vera leaf Aloe vera leaf | - | - | - | [2]  97 97, 226 💬
 | 
| 126 | Aloe vera gel | [1]  Aloe vera leaf Aloe vera leaf | - | - | - | [1]  97 97 💬
 | 
| 127 | Also referred to as 'MEDI2070' | - | - | - | - | [2]  96 96, 97 💬
 | 
| 128 | Also referred to as MEDI2070 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 129 | ALTH12-1:4 | - | - | - | - | [1]  97 97 💬
 | 
| 130 | ALTH12-2:4 | - | - | - | - | [1]  97 97 💬
 | 
| 131 | AMG 181 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 132 | AMG 592 | - | - | - | - | [3]  46 46, 49, 97 💬
 | 
| 133 | AMG181 | - | - | - | - | [1]  97 97 💬
 | 
| 134 | Amgevita | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 135 | AMGEVITA (Adalimumab biosimilar ) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 136 | Amgevita 40 mg Injektionslösung im Fertigpen | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 137 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 138 | Amgevita 40Mg Solution for Injection | - | - | - | - | [2]  96 96, 97 💬
 | 
| 139 | AMGEVITA® | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 140 | AMINOSALICYLIC ACID | [1]  Aminosalicylic acid Aminosalicylic acid | [1]  Aminosalicylic acid 
                
                    Aminosalicylic acid
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 141 | Amiselimod | [1]  Amiselimod Amiselimod | [1]  Amiselimod 
                
                    Amiselimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  97 97 💬
 | 
| 142 | Amitriptyline | [1]  Amitriptyline Amitriptyline | [1]  Amitriptyline 
                
                    Amitriptyline
                
             💬
 | [2]  SLC6A2 SLC6A2, SLC6A4 💬
 | [2]  Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [4]  78 78, 97, 226, 299 💬
 | 
| 143 | Amitriptyline hydrochloride | [1]  Amitriptyline Amitriptyline | [1]  Amitriptyline 
                
                    Amitriptyline
                
             💬
 | [2]  SLC6A2 SLC6A2, SLC6A4 💬
 | [2]  Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [1]  97 97 💬
 | 
| 144 | Amoxicillin | [2]  Amoxicillin Amoxicillin, Clavulanic acid | [3]  Amoxicillin 
                
                    Amoxicillin
                
            , 
                
                    Amoxicillin
                
            , 
                
                    Clavulanic acid
                
             💬
 | - | - | [7]  6 6, 46, 63, 96, 97, 222, 299 💬
 | 
| 145 | Amoxicillin and doxycyclin | [2]  Amoxicillin Amoxicillin, Doxycycline | [4]  Amoxicillin 
                
                    Amoxicillin
                
            , 
                
                    Doxycycline
                
            , 
                
                    Amoxicillin
                
            , 
                
                    Doxycycline
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 146 | Amoxicillin, metronidazole and doxycycline | [3]  Amoxicillin Amoxicillin, Doxycycline, Metronidazole | [5]  Amoxicillin 
                
                    Amoxicillin
                
            , 
                
                    Doxycycline
                
            , 
                
                    Metronidazole
                
            , 
                
                    Amoxicillin
                
            , 
                
                    Doxycycline
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 147 | AMT | - | - | - | - | [4]  8 8, 46, 97, 321 💬
 | 
| 148 | AMT-101 | - | - | - | - | [2]  46 46, 97 💬
 | 
| 149 | AMT-101 (oral) | - | - | - | - | [1]  97 97 💬
 | 
| 150 | Anakinra | [1]  Anakinra Anakinra | [1]  Anakinra 
                
                    Anakinra
                
             💬
 | [2]  IL1R1 IL1R1, IL1R2 💬
 | [15]  Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [16]  2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬
 | 
| 151 | AND (Andrographolide) | [1]  Andrographolide Andrographolide | - | - | - | [1]  97 97 💬
 | 
| 152 | Andecaliximab | - | - | - | - | [4]  46 46, 96, 97, 299 💬
 | 
| 153 | AndoSan | - | - | - | - | [2]  96 96, 97 💬
 | 
| 154 | ANDROGRAPHIS PANICULATA | - | - | - | - | [1]  97 97 💬
 | 
| 155 | ANDROGRAPHIS PANICULATA (ethanol extract) | [1]  Ethanol Ethanol | [1]  Ethanol 
                
                    Ethanol
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 156 | Andrographolide | [1]  Andrographolide Andrographolide | - | - | - | [1]  97 97 💬
 | 
| 157 | Anrukinzumab | [1]  Anrukinzumab Anrukinzumab | [1]  Anrukinzumab 
                
                    Anrukinzumab
                
             💬
 | [1]  IL13 IL13 💬
 | [8]  Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [1]  97 97 💬
 | 
| 158 | Anti Beta7 | - | - | - | - | [1]  97 97 💬
 | 
| 159 | Anti CD3 monoclonal antibody | - | - | - | - | [1]  97 97 💬
 | 
| 160 | Anti TNF therapy including infliximab | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 161 | Anti-CD3 | [1]  Muromonab Muromonab | - | - | - | [2]  96 96, 97 💬
 | 
| 162 | Anti-CD3 Monoclonal antibody | [1]  Muromonab Muromonab | - | - | - | [2]  96 96, 97 💬
 | 
| 163 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | [2]  96 96, 97 💬
 | 
| 164 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2]  96 96, 97 💬
 | 
| 165 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2]  96 96, 97 💬
 | 
| 166 | Anti-IP-10 Antibody | - | - | - | - | [1]  97 97 💬
 | 
| 167 | Anti-MAdCAM antibody | - | - | - | - | [2]  96 96, 97 💬
 | 
| 168 | Anti-TL1A | - | - | - | - | [1]  97 97 💬
 | 
| 169 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | [2]  96 96, 97 💬
 | 
| 170 | Anti-TNF Drug | - | - | - | - | [2]  96 96, 97 💬
 | 
| 171 | Anti-TNF therapy | - | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 172 | Anti-TNF: Infliximab (Infusion) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 173 | Anti-TNF:Adalimumab (Subcutaneus) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 174 | Antibiotic cocktail | - | - | - | - | [1]  97 97 💬
 | 
| 175 | AODG (Apigenin-7-O-glucuronide) | [1]  Apigenin Apigenin | - | - | - | [1]  97 97 💬
 | 
| 176 | APD334 | - | - | - | - | [5]  93 93, 96, 97, 98, 269 💬
 | 
| 177 | APD334 L-arginine | [2]  Arginine Arginine, L-arginine | [1]  Arginine 
                
                    Arginine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 178 | Apigenin | [1]  Apigenin Apigenin | - | - | - | [2]  6 6, 97 💬
 | 
| 179 | APL-1401 | - | - | - | - | [1]  97 97 💬
 | 
| 180 | Apremilast | [1]  Apremilast Apremilast | [1]  Apremilast 
                
                    Apremilast
                
             💬
 | [4]  PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
 | [5]  Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [7]  46 46, 50, 56, 97, 107, 162, 271 💬
 | 
| 181 | Apriso 0.375G ER CAP | - | - | - | - | [1]  97 97 💬
 | 
| 182 | APRISO 375 mg extended-release capsules | [1]  Manganese citrate Manganese citrate | - | - | - | [1]  97 97 💬
 | 
| 183 | APVO210 | - | - | - | - | [1]  97 97 💬
 | 
| 184 | Aquamin | - | - | - | - | [1]  97 97 💬
 | 
| 185 | Aquamin® | - | - | - | - | [1]  97 97 💬
 | 
| 186 | AR401959 L-arginine | [2]  Arginine Arginine, L-arginine | [1]  Arginine 
                
                    Arginine
                
             💬
 | - | - | [3]  96 96, 97, 98 💬
 | 
| 187 | Arginine | [1]  Arginine Arginine | [1]  Arginine 
                
                    Arginine
                
             💬
 | - | - | [11]  46 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299 💬
 | 
| 188 | ASA | - | - | - | - | [3]  13 13, 97, 251 💬
 | 
| 189 | ASACOL | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 190 | Asacol (mesalamine) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 191 | Asacol (mesalamine) Delayed-release Tablets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 192 | Asacol 400 mg | - | - | - | - | [1]  97 97 💬
 | 
| 193 | Asacol 400 mg (mesalamine) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 194 | Asacol 400 mg tablet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 195 | Asacol 400mg tablet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 196 | Asacol 800 mg (mesalamine) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 197 | Asacol 800 mg tablet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 198 | Asacol 800mg tablet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 199 | Asacol Delayed Release Tablets | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 200 | Asacol Delayed-Release Tablets | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 201 | Asacol tablet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 202 | Asacol® | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 203 | Asacol® 400 mg | - | - | - | - | [1]  97 97 💬
 | 
| 204 | ASC | - | - | - | - | [4]  36 36, 51, 96, 97 💬
 | 
| 205 | Ascorbic acid | [1]  Ascorbic acid Ascorbic acid | [1]  Ascorbic acid 
                
                    Ascorbic acid
                
             💬
 | - | - | [4]  10 10, 97, 206, 298 💬
 | 
| 206 | ASP015K | - | - | - | - | [2]  46 46, 97 💬
 | 
| 207 | ASP3291 | - | - | - | - | [1]  97 97 💬
 | 
| 208 | Aspergillus oryzae | [1]  Aspergillus oryzae Aspergillus oryzae | - | - | - | [1]  97 97 💬
 | 
| 209 | AST-120 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 210 | ATL-2502 | [1]  ATL-2502 ATL-2502 | - | - | - | [1]  97 97 💬
 | 
| 211 | Atorvastatin | [1]  Atorvastatin Atorvastatin | [1]  Atorvastatin 
                
                    Atorvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [19]  13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
 | 
| 212 | Atorvastatin 80mg | [1]  Atorvastatin Atorvastatin | [1]  Atorvastatin 
                
                    Atorvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  97 97 💬
 | 
| 213 | Atorvastatin Calcium | [2]  Atorvastatin Atorvastatin, Calcium | [1]  Atorvastatin 
                
                    Atorvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [2]  97 97, 265 💬
 | 
| 214 | AVONEX | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2]  13 13, 97 💬
 | 
| 215 | AVX 470 | - | - | - | - | [1]  97 97 💬
 | 
| 216 | AZA | - | - | - | - | [4]  11 11, 40, 96, 97 💬
 | 
| 217 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | [1]  97 97 💬
 | 
| 218 | AZAFOR 50mg | - | - | - | - | [1]  97 97 💬
 | 
| 219 | Azathioprine | [1]  Azathioprine Azathioprine | [1]  Azathioprine 
                
                    Azathioprine
                
             💬
 | - | - | [21]  6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬
 | 
| 220 | Azathioprine (AZA) | [1]  Azathioprine Azathioprine | [1]  Azathioprine 
                
                    Azathioprine
                
             💬
 | - | - | [3]  13 13, 19, 97 💬
 | 
| 221 | Azathioprine (AZA) or 6-mercaptopurine (6-MP) | [2]  Azathioprine Azathioprine, Mercaptopurine | [3]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Azathioprine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [2]  96 96, 97 💬
 | 
| 222 | Azathioprine (Imuran) 50 mg Overencapsulated Tablet | [1]  Azathioprine Azathioprine | [1]  Azathioprine 
                
                    Azathioprine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 223 | Azathioprine and Allopurinol | [2]  Allopurinol Allopurinol, Azathioprine | [2]  Allopurinol 
                
                    Allopurinol
                
            , 
                
                    Azathioprine
                
             💬
 | [1]  XDH XDH 💬
 | [6]  Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | [1]  97 97 💬
 | 
| 224 | AZATHIOPRINE BP | [1]  Azathioprine Azathioprine | [1]  Azathioprine 
                
                    Azathioprine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 225 | Azathioprine or 6-mercaptopurine | [2]  Azathioprine Azathioprine, Mercaptopurine | [3]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Azathioprine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [2]  96 96, 97 💬
 | 
| 226 | Azatioprina | [1]  Azathioprine Azathioprine | [1]  Azathioprine 
                
                    Azathioprine
                
             💬
 | - | - | [3]  13 13, 96, 97 💬
 | 
| 227 | B2-ASmedic | - | - | - | - | [1]  97 97 💬
 | 
| 228 | B: 2 dosis | - | - | - | - | [1]  97 97 💬
 | 
| 229 | Bacteriotherapy | - | - | - | - | [2]  96 96, 97 💬
 | 
| 230 | Balsalazide | [1]  Balsalazide Balsalazide | [1]  Balsalazide 
                
                    Balsalazide
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 231 | Balsalazide Disodium | [1]  Balsalazide Balsalazide | [1]  Balsalazide 
                
                    Balsalazide
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 232 | Baminercept | [1]  Baminercept Baminercept | [1]  Baminercept 
                
                    Baminercept
                
             💬
 | [1]  LTB LTB 💬
 | [3]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4]  13 13, 46, 53, 97 💬
 | 
| 233 | Bascial prescription plus or minus herbs depend on symptoms | - | - | - | - | [1]  97 97 💬
 | 
| 234 | Basiliximab | [1]  Basiliximab Basiliximab | [1]  Basiliximab 
                
                    Basiliximab
                
             💬
 | [1]  IL2RA IL2RA 💬
 | [11]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [5]  2 2, 50, 97, 222, 228 💬
 | 
| 235 | BBT-401-1S | - | - | - | - | [1]  97 97 💬
 | 
| 236 | BBT-401-1S, Multiple doses | - | - | - | - | [1]  97 97 💬
 | 
| 237 | BBT-401-1S, Single dose | - | - | - | - | [1]  97 97 💬
 | 
| 238 | Beclometasone | - | - | - | - | [1]  97 97 💬
 | 
| 239 | Beclometasone dipropionate | [1]  Beclomethasone dipropionate Beclomethasone dipropionate | [1]  Beclomethasone dipropionate 
                
                    Beclomethasone dipropionate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2]  85 85, 97 💬
 | 
| 240 | Beclomethasone dipropionate | [1]  Beclomethasone dipropionate Beclomethasone dipropionate | [1]  Beclomethasone dipropionate 
                
                    Beclomethasone dipropionate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2]  97 97, 98 💬
 | 
| 241 | Beclomethasone diproprionate | - | - | - | - | [1]  97 97 💬
 | 
| 242 | Berberine | [1]  Berberine Berberine | - | - | - | [2]  97 97, 265 💬
 | 
| 243 | Berberine Chloride | [2]  Berberine Berberine, Chloride ion | - | - | - | [1]  97 97 💬
 | 
| 244 | Bertilimumab | - | - | - | - | [2]  97 97, 162 💬
 | 
| 245 | Beta-1,3/1,6-D-Glucan | - | - | - | - | [1]  97 97 💬
 | 
| 246 | Bezlotoxumab | [1]  Bezlotoxumab Bezlotoxumab | [1]  Bezlotoxumab 
                
                    Bezlotoxumab
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 247 | BG9418 (interferon beta-1a) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2]  13 13, 97 💬
 | 
| 248 | BG9924 | - | - | - | - | [2]  46 46, 97 💬
 | 
| 249 | BGP-014 | - | - | - | - | [1]  97 97 💬
 | 
| 250 | BGP-014 Capsules | - | - | - | - | [1]  97 97 💬
 | 
| 251 | BI 655130 | - | - | - | - | [3]  37 37, 96, 97 💬
 | 
| 252 | BIAP | - | - | - | - | [2]  46 46, 97 💬
 | 
| 253 | Bifidobacterium breve | [1]  Bifidobacterium breve Bifidobacterium breve | - | - | - | [1]  97 97 💬
 | 
| 254 | Bifidobacterium infantis | [1]  Bifidobacterium longum infantis Bifidobacterium longum infantis | - | - | - | [2]  96 96, 97 💬
 | 
| 255 | Bifidobacterium infantis 35624 | [1]  Bifidobacterium longum infantis Bifidobacterium longum infantis | - | - | - | [2]  96 96, 97 💬
 | 
| 256 | BIMEKIZUMAB | [1]  Bimekizumab Bimekizumab | [1]  Bimekizumab 
                
                    Bimekizumab
                
             💬
 | [2]  IL17A IL17A, IL17F 💬
 | [6]  Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [3]  46 46, 97, 271 💬
 | 
| 257 | Bio-enhanced Curcumin Soft Gelatin Capsule | [2]  Curcumin Curcumin, Gelatin | [2]  Gelatin 
                
                    Gelatin
                
            , 
                
                    Donkey glue
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 258 | Biological Drug | - | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 259 | Biologically active human fecal microbiota | - | - | - | - | [1]  97 97 💬
 | 
| 260 | Biologics | - | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 261 | Biopsies | - | - | - | - | [1]  97 97 💬
 | 
| 262 | Biosimilar | - | - | - | - | [4]  46 46, 96, 97, 271 💬
 | 
| 263 | Biosimilar Infliximab | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 264 | BITTER CANDYTUFT FRESH PLANT EXTRACT | - | - | - | - | [1]  97 97 💬
 | 
| 265 | Bitterschleifenblume-ganzpflanze 1,5ml/10ml | - | - | - | - | [1]  97 97 💬
 | 
| 266 | BL-7040 | - | - | - | - | [1]  97 97 💬
 | 
| 267 | Blood sample | - | - | - | - | [20]  8 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299 💬
 | 
| 268 | Blood samples | - | - | - | - | [9]  13 13, 41, 51, 61, 97, 227, 240, 271, 280 💬
 | 
| 269 | BMS-188667 | - | - | - | - | [9]  46 46, 49, 53, 65, 96, 97, 107, 222, 271 💬
 | 
| 270 | BMS-936557 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 271 | BMS-986165 | - | - | - | - | [3]  49 49, 96, 97 💬
 | 
| 272 | BMS-986166 | - | - | - | - | [1]  97 97 💬
 | 
| 273 | BMS-986184 | - | - | - | - | [1]  97 97 💬
 | 
| 274 | BMS986165 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 275 | Boulardii | - | - | - | - | [2]  96 96, 97 💬
 | 
| 276 | Bovine intestinal alkaline phosphatase (BIAP) | [1]  Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1]  97 97 💬
 | 
| 277 | Bovine-Calf Alkaline Phosphatase (BIAP) | [1]  Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1]  97 97 💬
 | 
| 278 | Bovine-Calf Alkaline Phosphatase BIAP | [1]  Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1]  97 97 💬
 | 
| 279 | BRAZIKUMAB | [1]  Brazikumab Brazikumab | [1]  Brazikumab 
                
                    Brazikumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 280 | Brazikumab Induction Dose | [1]  Brazikumab Brazikumab | [1]  Brazikumab 
                
                    Brazikumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 281 | Brazikumab Maintenance Dose | [1]  Brazikumab Brazikumab | [1]  Brazikumab 
                
                    Brazikumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 282 | Brepocitinib 25 mg | - | - | - | - | [2]  96 96, 97 💬
 | 
| 283 | Brepocitinib 5 mg | - | - | - | - | [2]  96 96, 97 💬
 | 
| 284 | Broccoli | [1]  Broccoli Broccoli | - | - | - | [3]  36 36, 97, 299 💬
 | 
| 285 | BT | - | - | - | - | [3]  96 96, 97, 98 💬
 | 
| 286 | BT-11 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 287 | BT-11 (1000 mg) | - | - | - | - | [1]  97 97 💬
 | 
| 288 | BT-11 (500 mg) | - | - | - | - | [1]  97 97 💬
 | 
| 289 | BT-11 1000mg | - | - | - | - | [3]  96 96, 97, 98 💬
 | 
| 290 | BT-11 500 mg | - | - | - | - | [2]  96 96, 97 💬
 | 
| 291 | BT-11 Active | - | - | - | - | [2]  96 96, 97 💬
 | 
| 292 | BT051 200 mg | - | - | - | - | [1]  97 97 💬
 | 
| 293 | BT051 3200 mg | - | - | - | - | [1]  97 97 💬
 | 
| 294 | BT051 800 mg | - | - | - | - | [1]  97 97 💬
 | 
| 295 | Budenofalk 2mg rectal foam | - | - | - | - | [1]  97 97 💬
 | 
| 296 | Budenofalk 3mg | - | - | - | - | [2]  93 93, 97 💬
 | 
| 297 | Budenofalk rectal foam | - | - | - | - | [1]  97 97 💬
 | 
| 298 | Budenofalk® suppositories | - | - | - | - | [1]  97 97 💬
 | 
| 299 | Budenofalk® suppositories (BUS) | - | - | - | - | [1]  97 97 💬
 | 
| 300 | BUDESONIDE | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9]  66 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
 | 
| 301 | Budesonide (6 mg) | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 302 | Budesonide (9 mg) | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 303 | Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 304 | Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 305 | Budesonide 9 mg capsules, hard (BUX-PV) | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 306 | Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 307 | Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 308 | Budesonide MMX | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 309 | Budesonide MMX 6 mg Tablet | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 310 | Budesonide MMX® | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 311 | Budesonide MMX® 6 mg | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 312 | Budesonide MMX® 9 mg | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 313 | Budesonide-MMX | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 314 | Budesonide-MMX® | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 315 | Budesonide-MMX® 6 mg | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 316 | Budesonide-MMX® 9 mg | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 317 | Budesonide-MMX™ | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 318 | Butanoic acid | [1]  Butyric Acid Butyric Acid | - | - | - | [3]  34 34, 51, 97 💬
 | 
| 319 | Butyrate | [1]  Butyric Acid Butyric Acid | - | - | - | [4]  46 46, 97, 156, 291 💬
 | 
| 320 | By demand | - | - | - | - | [2]  96 96, 97 💬
 | 
| 321 | Caffeine | [1]  Caffeine Caffeine | [2]  Caffeine 
                
                    Caffeine
                
            , 
                
                    Caffeine hydrate
                
             💬
 | [11]  ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
 | [22]  Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8]  2 2, 6, 21, 46, 78, 96, 97, 265 💬
 | 
| 322 | Calcio | [1]  Calcium Calcium | - | - | - | [4]  13 13, 96, 97, 274 💬
 | 
| 323 | Calcitonin nasal spray (salmon) | [1]  Salmon, unspecified Salmon, unspecified | - | - | - | [2]  96 96, 97 💬
 | 
| 324 | Calcium | [2]  Calcium Calcium, Calcium carbonate | [2]  Calcium carbonate 
                
                    Calcium carbonate
                
            , 
                
                    Calcium carbonate
                
             💬
 | - | - | [27]  6 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
 | 
| 325 | Caltrate | - | - | - | - | [1]  97 97 💬
 | 
| 326 | Cannabidiol | [1]  Cannabidiol Cannabidiol | [1]  Cannabidiol 
                
                    Cannabidiol
                
             💬
 | [2]  CNR1 CNR1, CNR2 💬
 | [4]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [18]  6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
 | 
| 327 | Cannabis | [1]  Medical Cannabis Medical Cannabis | - | - | - | [7]  2 2, 6, 13, 19, 90, 96, 97 💬
 | 
| 328 | Cannabis, Medical | [1]  Medical Cannabis Medical Cannabis | - | - | - | [5]  2 2, 6, 13, 96, 97 💬
 | 
| 329 | Carbon | [1]  Activated charcoal Activated charcoal | - | - | - | [6]  6 6, 85, 86, 96, 97, 158 💬
 | 
| 330 | Carbon dioxide | [2]  Activated charcoal Activated charcoal, Carbon dioxide | [1]  Carbon dioxide 
                
                    Carbon dioxide
                
             💬
 | - | - | [2]  97 97, 158 💬
 | 
| 331 | Carnitine | [1]  Levocarnitine Levocarnitine | [1]  Levocarnitine 
                
                    Levocarnitine
                
             💬
 | - | - | [9]  5 5, 13, 58, 86, 96, 97, 265, 298, 316 💬
 | 
| 332 | Carrageenan | - | - | - | - | [1]  97 97 💬
 | 
| 333 | CARVI EXTRACTUM FLUIDUM | - | - | - | - | [1]  97 97 💬
 | 
| 334 | Casein | [1]  Casein Casein | - | - | - | [1]  97 97 💬
 | 
| 335 | Casein glycomacropeptide (CGMP) | [1]  Casein Casein | - | - | - | [1]  97 97 💬
 | 
| 336 | CAT-354 | - | - | - | - | [1]  97 97 💬
 | 
| 337 | Catridecacog | [1]  Catridecacog Catridecacog | [1]  Catridecacog 
                
                    Catridecacog
                
             💬
 | - | - | [2]  97 97, 288 💬
 | 
| 338 | CB-01-02 | - | - | - | - | [1]  97 97 💬
 | 
| 339 | CB-01-05-MMX | - | - | - | - | [1]  97 97 💬
 | 
| 340 | CBP-307 | - | - | - | - | [1]  97 97 💬
 | 
| 341 | CC | - | - | - | - | [13]  28 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 💬
 | 
| 342 | CC-10004 | - | - | - | - | [5]  46 46, 56, 97, 162, 271 💬
 | 
| 343 | CD | - | - | - | - | [8]  6 6, 13, 46, 51, 63, 96, 97, 265 💬
 | 
| 344 | CD7 CAR T-cells | - | - | - | - | [3]  50 50, 96, 97 💬
 | 
| 345 | Ceftriaxone | [1]  Ceftriaxone Ceftriaxone | [1]  Ceftriaxone 
                
                    Ceftriaxone
                
             💬
 | - | - | [4]  2 2, 6, 46, 97 💬
 | 
| 346 | Cefuroxime | [1]  Cefuroxime Cefuroxime | [1]  Cefuroxime 
                
                    Cefuroxime
                
             💬
 | - | - | [2]  97 97, 299 💬
 | 
| 347 | Certolizumab Pegol | [1]  Certolizumab pegol Certolizumab pegol | [1]  Certolizumab pegol 
                
                    Certolizumab pegol
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8]  37 37, 46, 49, 96, 97, 107, 226, 271 💬
 | 
| 348 | CGMP protein | - | - | - | - | [1]  97 97 💬
 | 
| 349 | Chloride | [1]  Chloride ion Chloride ion | - | - | - | [28]  6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬
 | 
| 350 | Chlorogenic Acid | [1]  Chlorogenic Acid Chlorogenic Acid | - | - | - | [1]  97 97 💬
 | 
| 351 | CHOLECALCIFEROL | [1]  Cholecalciferol Cholecalciferol | [1]  Cholecalciferol 
                
                    Cholecalciferol
                
             💬
 | [1]  VDR VDR 💬
 | [5]  Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [9]  13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
 | 
| 352 | Ciclosporin | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [13]  26 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬
 | 
| 353 | CICLOSPORINA | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [4]  49 49, 60, 97, 228 💬
 | 
| 354 | CIMZIA | [1]  Certolizumab pegol Certolizumab pegol | [1]  Certolizumab pegol 
                
                    Certolizumab pegol
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5]  46 46, 49, 96, 97, 271 💬
 | 
| 355 | Ciprofloxacin | [1]  Ciprofloxacin Ciprofloxacin | [1]  Ciprofloxacin 
                
                    Ciprofloxacin
                
             💬
 | - | - | [5]  2 2, 60, 96, 97, 299 💬
 | 
| 356 | CLA | - | - | - | - | [1]  97 97 💬
 | 
| 357 | CLA (Chlorogenic acid) | [1]  Chlorogenic Acid Chlorogenic Acid | - | - | - | [1]  97 97 💬
 | 
| 358 | Clarithromycin | [1]  Clarithromycin Clarithromycin | [1]  Clarithromycin 
                
                    Clarithromycin
                
             💬
 | - | - | [8]  6 6, 63, 84, 96, 97, 222, 228, 299 💬
 | 
| 359 | Clipper | - | - | - | - | [1]  97 97 💬
 | 
| 360 | Clipper 30 cpr 5mg R.M. | - | - | - | - | [1]  97 97 💬
 | 
| 361 | CLIPPER*30CPR 5MG R.M. | - | - | - | - | [1]  97 97 💬
 | 
| 362 | Clotrimazole | [1]  Clotrimazole Clotrimazole | [1]  Clotrimazole 
                
                    Clotrimazole
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 363 | CNTO 148 | - | - | - | - | [4]  46 46, 84, 97, 271 💬
 | 
| 364 | CNTO-148 | - | - | - | - | [1]  97 97 💬
 | 
| 365 | CNTO1275 | - | - | - | - | [6]  46 46, 49, 84, 93, 96, 97 💬
 | 
| 366 | CNTO148 | - | - | - | - | [5]  46 46, 84, 96, 97, 107 💬
 | 
| 367 | CNTO1959 | - | - | - | - | [4]  37 37, 41, 96, 97 💬
 | 
| 368 | CNTO312 | - | - | - | - | [1]  97 97 💬
 | 
| 369 | Coamoxiclav | - | - | - | - | [1]  97 97 💬
 | 
| 370 | COBITOLIMOD | [1]  Cobitolimod Cobitolimod | [1]  Cobitolimod 
                
                    Cobitolimod
                
             💬
 | [1]  TLR9 TLR9 💬
 | [9]  African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 371 | Cobitolimod 250 mg | [1]  Cobitolimod Cobitolimod | [1]  Cobitolimod 
                
                    Cobitolimod
                
             💬
 | [1]  TLR9 TLR9 💬
 | [9]  African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 372 | Cobitolimod 500 mg | [1]  Cobitolimod Cobitolimod | [1]  Cobitolimod 
                
                    Cobitolimod
                
             💬
 | [1]  TLR9 TLR9 💬
 | [9]  African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 373 | Cobitolimod 500mg | [1]  Cobitolimod Cobitolimod | [1]  Cobitolimod 
                
                    Cobitolimod
                
             💬
 | [1]  TLR9 TLR9 💬
 | [9]  African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 374 | Coffee | [2]  Arabica coffee bean Arabica coffee bean, Coffea arabica seed, roasted | - | - | - | [1]  97 97 💬
 | 
| 375 | COFFEE COAL | [2]  Arabica coffee bean Arabica coffee bean, Coffea arabica seed, roasted | - | - | - | [1]  97 97 💬
 | 
| 376 | COLAL PRED | - | - | - | - | [1]  97 97 💬
 | 
| 377 | COLAL-PRED | - | - | - | - | [1]  97 97 💬
 | 
| 378 | COLAL-PRED® | - | - | - | - | [1]  97 97 💬
 | 
| 379 | Colazide | - | - | - | - | [1]  97 97 💬
 | 
| 380 | Coltect | - | - | - | - | [1]  97 97 💬
 | 
| 381 | Combination Oral Budesonide and Rectal Hydrocortisone | [2]  Budesonide Budesonide, Hydrocortisone | [2]  Hydrocortisone 
                
                    Hydrocortisone
                
            , 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 382 | Combination Product: Beclomethasone dipropionate in addition to MC-EVOO | [1]  Beclomethasone dipropionate Beclomethasone dipropionate | [1]  Beclomethasone dipropionate 
                
                    Beclomethasone dipropionate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 383 | Combination Product: Beclomethasone dipropionate in addition to refined oil | [1]  Beclomethasone dipropionate Beclomethasone dipropionate | [1]  Beclomethasone dipropionate 
                
                    Beclomethasone dipropionate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 384 | Combination Product: Humira (adalimumab) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 385 | Conventional treatment | - | - | - | - | [1]  97 97 💬
 | 
| 386 | Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 387 | Corticosteroid | - | - | - | - | [9]  13 13, 42, 43, 44, 45, 66, 96, 97, 222 💬
 | 
| 388 | Corticosteroids | - | - | - | - | [12]  41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
 | 
| 389 | Corticosteroids +immune suppressive +amino salicylic acid | [1]  Salicylic acid Salicylic acid | [1]  Salicylic acid 
                
                    Salicylic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 390 | Corticosteroids only | - | - | - | - | [1]  97 97 💬
 | 
| 391 | CortimentMMX 9 mg | - | - | - | - | [1]  97 97 💬
 | 
| 392 | CosmoFer | - | - | - | - | [3]  86 86, 96, 97 💬
 | 
| 393 | CosmoFer 50mg/ml solution for infusion or injection | - | - | - | - | [2]  96 96, 97 💬
 | 
| 394 | Cotrimoxazole | - | - | - | - | [2]  85 85, 97 💬
 | 
| 395 | CP | - | - | - | - | [6]  6 6, 46, 96, 97, 107, 271 💬
 | 
| 396 | CP- 690 550 | - | - | - | - | [1]  97 97 💬
 | 
| 397 | CP-690, 550-10 | - | - | - | - | [2]  97 97, 107 💬
 | 
| 398 | CP-690,500 5 mg | - | - | - | - | [1]  97 97 💬
 | 
| 399 | CP-690,550 | - | - | - | - | [5]  46 46, 96, 97, 107, 271 💬
 | 
| 400 | CP-690,550 10 mg | - | - | - | - | [1]  97 97 💬
 | 
| 401 | CP-690,550-10 | - | - | - | - | [5]  46 46, 96, 97, 107, 271 💬
 | 
| 402 | CP690,550 | - | - | - | - | [2]  46 46, 97 💬
 | 
| 403 | CS (corticosteroids) Only | - | - | - | - | [1]  97 97 💬
 | 
| 404 | CT-P13 | - | - | - | - | [4]  46 46, 96, 97, 271 💬
 | 
| 405 | CT-P13 SC (Infliximab) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 406 | Curcumin | [1]  Curcumin Curcumin | - | - | - | [10]  2 2, 13, 46, 67, 74, 94, 96, 97, 139, 299 💬
 | 
| 407 | Curcumin Supplementation | [1]  Curcumin Curcumin | - | - | - | [1]  97 97 💬
 | 
| 408 | Cyclosporin | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [17]  38 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬
 | 
| 409 | Cyclosporine | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37]  11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬
 | 
| 410 | Cyclosporine (USAN) | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  97 97 💬
 | 
| 411 | CYCLOSPORINE VS INFLIXIMAB | [2]  Cyclosporine Cyclosporine, Infliximab | [2]  Cyclosporine 
                
                    Cyclosporine
                
            , 
                
                    Infliximab
                
             💬
 | [6]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬
 | [86]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 412 | CyCol | - | - | - | - | [1]  97 97 💬
 | 
| 413 | CyCol™ | - | - | - | - | [1]  97 97 💬
 | 
| 414 | Cytochrome P450 (CYP) Substrates | - | - | - | - | [2]  96 96, 97 💬
 | 
| 415 | D-Proline | [2]  D-Proline D-Proline, Proline | [1]  Proline 
                
                    Proline
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 416 | D.3.6.2.1 - valore: 45 / 0.45 mg/ml | - | - | - | - | [1]  97 97 💬
 | 
| 417 | D.3.6.2.1 - valore: 5 o 10 mg/kg | - | - | - | - | [1]  97 97 💬
 | 
| 418 | D3 VitaCaps® | - | - | - | - | [2]  96 96, 97 💬
 | 
| 419 | DACLIZUMAB | [1]  Daclizumab Daclizumab | [1]  Daclizumab 
                
                    Daclizumab
                
             💬
 | [1]  IL2RA IL2RA 💬
 | [11]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [8]  13 13, 56, 60, 65, 97, 107, 283, 284 💬
 | 
| 420 | DACORTIN | - | - | - | - | [1]  97 97 💬
 | 
| 421 | DAND (14-Deoxyandrographolide) | - | - | - | - | [1]  97 97 💬
 | 
| 422 | DDAND (14-deoxy-11,12-didehydroandrographolide) | - | - | - | - | [1]  97 97 💬
 | 
| 423 | Decortin H | - | - | - | - | [3]  66 66, 97, 145 💬
 | 
| 424 | Decortin H 1 mg | - | - | - | - | [1]  97 97 💬
 | 
| 425 | Decortin H 10mg | - | - | - | - | [1]  97 97 💬
 | 
| 426 | Decortin H 20mg | - | - | - | - | [1]  97 97 💬
 | 
| 427 | Decortin H 50 mg | - | - | - | - | [1]  97 97 💬
 | 
| 428 | Decortin H 5mg | - | - | - | - | [1]  97 97 💬
 | 
| 429 | Dekavil | - | - | - | - | [2]  46 46, 97 💬
 | 
| 430 | Dekristol | - | - | - | - | [2]  13 13, 97 💬
 | 
| 431 | Delayed and extended release mesalazine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 432 | Deligoparin | - | - | - | - | [1]  97 97 💬
 | 
| 433 | Delmitide acetate | [1]  Acetate Acetate | - | - | - | [1]  97 97 💬
 | 
| 434 | DELTACORTENE | - | - | - | - | [2]  43 43, 97 💬
 | 
| 435 | Deltacortene 10 cpr 25mg | - | - | - | - | [1]  97 97 💬
 | 
| 436 | Deltacortene 20 cpr 5mg | - | - | - | - | [1]  97 97 💬
 | 
| 437 | DELTACORTENE FORTE*10CPR 25MG | - | - | - | - | [2]  46 46, 97 💬
 | 
| 438 | DELTACORTENE*20CPR 5MG | - | - | - | - | [3]  49 49, 97, 113 💬
 | 
| 439 | Dersalazina sodica | - | - | - | - | [1]  97 97 💬
 | 
| 440 | Dersalazine | [1]  Dersalazine Dersalazine | - | - | - | [1]  97 97 💬
 | 
| 441 | Dersalazine sodium | [1]  Dersalazine Dersalazine | - | - | - | [1]  97 97 💬
 | 
| 442 | Deucravacitinib | [1]  Deucravacitinib Deucravacitinib | [1]  Deucravacitinib 
                
                    Deucravacitinib
                
             💬
 | [1]  TYK2 TYK2 💬
 | [16]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬 | [3]  49 49, 96, 97 💬
 | 
| 443 | Dexamethasone | [1]  Dexamethasone Dexamethasone | [1]  Dexamethasone 
                
                    Dexamethasone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [22]  13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
 | 
| 444 | Dexamethasone 21-phosphate | [2]  Dexamethasone Dexamethasone, Phosphate ion | [1]  Dexamethasone 
                
                    Dexamethasone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 445 | Dextran | [1]  Dextran Dextran | [1]  Dextran 1 
                
                    Dextran 1
                
             💬
 | - | - | [4]  2 2, 62, 96, 97 💬
 | 
| 446 | DEXTRAN 1 FOR INJECTION | [1]  Dextran Dextran | [1]  Dextran 1 
                
                    Dextran 1
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 447 | Dextromethorphan | [1]  Dextromethorphan Dextromethorphan | [1]  Dextromethorphan 
                
                    Dextromethorphan
                
             💬
 | [6]  GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
 | [20]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [11]  2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬
 | 
| 448 | Diet | - | - | - | - | [4]  86 86, 97, 240, 299 💬
 | 
| 449 | DIMS0150 | - | - | - | - | [1]  97 97 💬
 | 
| 450 | Diosmin | [1]  Diosmin Diosmin | [1]  Diosmin 
                
                    Diosmin
                
             💬
 | - | - | [3]  46 46, 97, 265 💬
 | 
| 451 | Doxycyclin | [1]  Doxycycline Doxycycline | [2]  Doxycycline 
                
                    Doxycycline
                
            , 
                
                    Doxycycline
                
             💬
 | - | - | [2]  97 97, 299 💬
 | 
| 452 | Doxycycline | [1]  Doxycycline Doxycycline | [2]  Doxycycline 
                
                    Doxycycline
                
            , 
                
                    Doxycycline
                
             💬
 | - | - | [17]  13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
 | 
| 453 | Dukoral | [5]  Recombinant Cholera Toxin B Subunit Recombinant Cholera Toxin B Subunit, Vibrio cholerae Inaba 48 classical biotype, heat inactivated, Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, heat inactivated | - | - | - | [1]  97 97 💬
 | 
| 454 | Dupilumab | [1]  Dupilumab Dupilumab | [1]  Dupilumab 
                
                    Dupilumab
                
             💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5]  51 51, 97, 98, 160, 162 💬
 | 
| 455 | E. coli Nissle | - | - | - | - | [1]  97 97 💬
 | 
| 456 | E. coli Nissle 1917 (Mutaflor®) | - | - | - | - | [1]  97 97 💬
 | 
| 457 | E400 elimination | - | - | - | - | [1]  97 97 💬
 | 
| 458 | E6007 | - | - | - | - | [1]  97 97 💬
 | 
| 459 | Ecologic 825 | - | - | - | - | [1]  97 97 💬
 | 
| 460 | EFAVALEUKIN ALFA | [1]  Efavaleukin alfa Efavaleukin alfa | [1]  Efavaleukin alfa 
                
                    Efavaleukin alfa
                
             💬
 | - | - | [2]  49 49, 97 💬
 | 
| 461 | Efmarodocokin alfa | [1]  Efmarodocokin alfa Efmarodocokin alfa | [1]  Efmarodocokin alfa 
                
                    Efmarodocokin alfa
                
             💬
 | [1]  IL22 IL22 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2]  96 96, 97 💬
 | 
| 462 | EGF enema | - | - | - | - | [1]  97 97 💬
 | 
| 463 | Eicosapentaenoic acid | [1]  Icosapent Icosapent | [1]  Icosapent 
                
                    Icosapent
                
             💬
 | - | - | [6]  49 49, 96, 97, 296, 297, 338 💬
 | 
| 464 | EMEA/H/C/000240 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 465 | EMEA/H/C/000481 | - | - | - | - | [1]  97 97 💬
 | 
| 466 | Empagliflozin | [1]  Empagliflozin Empagliflozin | [1]  Empagliflozin 
                
                    Empagliflozin
                
             💬
 | [1]  SLC5A2 SLC5A2 💬
 | - | [6]  58 58, 65, 67, 72, 97, 257 💬
 | 
| 467 | Empagliflozin 10 MG | [1]  Empagliflozin Empagliflozin | [1]  Empagliflozin 
                
                    Empagliflozin
                
             💬
 | [1]  SLC5A2 SLC5A2 💬
 | - | [2]  58 58, 97 💬
 | 
| 468 | EN | - | - | - | - | [3]  6 6, 46, 97 💬
 | 
| 469 | Encapsulated faecal microbiota | - | - | - | - | [1]  97 97 💬
 | 
| 470 | Encapsulated faecal microbiota filtrate | - | - | - | - | [1]  97 97 💬
 | 
| 471 | Encapsulated Mesalamine Granules (eMG) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 472 | Entecavir | [1]  Entecavir Entecavir | [2]  Entecavir 
                
                    Entecavir
                
            , 
                
                    Entecavir
                
             💬
 | - | - | [6]  46 46, 56, 96, 97, 107, 271 💬
 | 
| 473 | Entocort CR | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2]  96 96, 97 💬
 | 
| 474 | Entocort EC® 3 mg | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 475 | Entocort® CR | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 476 | Entyvio | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3]  94 94, 96, 97 💬
 | 
| 477 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 478 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 479 | ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 480 | Entyvio 300 mg | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 481 | Entyvio 300mg | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 482 | Epaxal Berna (virosomal hepatitis A vaccine) | [1]  Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [2]  96 96, 97 💬
 | 
| 483 | Epidermal growth factor | - | - | - | - | [1]  97 97 💬
 | 
| 484 | Epidermal growth factor enema | - | - | - | - | [1]  97 97 💬
 | 
| 485 | Ergocalciferol | [1]  Ergocalciferol Ergocalciferol | [1]  Ergocalciferol 
                
                    Ergocalciferol
                
             💬
 | [1]  VDR VDR 💬
 | [5]  Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5]  46 46, 84, 96, 97, 299 💬
 | 
| 486 | Ethanol | [1]  Ethanol Ethanol | [1]  Ethanol 
                
                    Ethanol
                
             💬
 | - | - | [3]  97 97, 279, 280 💬
 | 
| 487 | Etrasimod | [1]  Etrasimod Etrasimod | [1]  Etrasimod 
                
                    Etrasimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3]  96 96, 97, 98 💬
 | 
| 488 | Etrasimod L-arginine | [3]  Arginine Arginine, Etrasimod, L-arginine | [2]  Arginine 
                
                    Arginine
                
            , 
                
                    Etrasimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3]  96 96, 97, 98 💬
 | 
| 489 | ETROLIZUMAB | [1]  Etrolizumab Etrolizumab | [1]  Etrolizumab 
                
                    Etrolizumab
                
             💬
 | [1]  ITGB7 ITGB7 💬
 | [11]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | [2]  96 96, 97 💬
 | 
| 490 | Etrozulimab | - | - | - | - | [1]  97 97 💬
 | 
| 491 | ExoFlo | - | - | - | - | [2]  96 96, 97 💬
 | 
| 492 | Exposure to golimumab | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 493 | F8IL10 | - | - | - | - | [2]  46 46, 97 💬
 | 
| 494 | Factor XIII | [1]  Factor XIII (human) Factor XIII (human) | - | - | - | [3]  51 51, 97, 288 💬
 | 
| 495 | Faecal matter | - | - | - | - | [1]  97 97 💬
 | 
| 496 | Faecal Microbiota Transplant | - | - | - | - | [1]  97 97 💬
 | 
| 497 | Faecal microbiota transplantation | - | - | - | - | [5]  46 46, 84, 96, 97, 271 💬
 | 
| 498 | FE 999301 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 499 | Fecal Microbial transplant | - | - | - | - | [2]  96 96, 97 💬
 | 
| 500 | Fecal Microbial Transplantation | - | - | - | - | [2]  96 96, 97 💬
 | 
| 501 | Fecal microbiota | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 502 | Fecal microbiota capsule | - | - | - | - | [1]  97 97 💬
 | 
| 503 | Fecal Microbiota Enema | - | - | - | - | [1]  97 97 💬
 | 
| 504 | Fecal Microbiota Transplant | - | - | - | - | [2]  96 96, 97 💬
 | 
| 505 | Fecal Microbiota Transplant (FMT) | - | - | - | - | [2]  96 96, 97 💬
 | 
| 506 | Fecal microbiota transplantation | - | - | - | - | [5]  2 2, 66, 94, 96, 97 💬
 | 
| 507 | Fecal Microbiota Transplantation (FMT) | - | - | - | - | [2]  96 96, 97 💬
 | 
| 508 | Fecal Microbiota Transplantation (FMT), OpenBiome | - | - | - | - | [1]  97 97 💬
 | 
| 509 | Fecal Microbiota Transplantation by Intra-rectal enemas | - | - | - | - | [1]  97 97 💬
 | 
| 510 | Fecal Microbiota Transplantation by Stool capsules | - | - | - | - | [1]  97 97 💬
 | 
| 511 | Fecal transplantation | - | - | - | - | [1]  97 97 💬
 | 
| 512 | Fenofibrate | [1]  Fenofibrate Fenofibrate | [1]  Fenofibrate 
                
                    Fenofibrate
                
             💬
 | [1]  PPARA PPARA 💬
 | [10]  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [6]  8 8, 79, 93, 94, 97, 265 💬
 | 
| 513 | Fenofibrate 160mg | [1]  Fenofibrate Fenofibrate | [1]  Fenofibrate 
                
                    Fenofibrate
                
             💬
 | [1]  PPARA PPARA 💬
 | [10]  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1]  97 97 💬
 | 
| 514 | FERRIC CARBOXYMALTOSE | [1]  Ferric carboxymaltose Ferric carboxymaltose | [1]  Ferric carboxymaltose 
                
                    Ferric carboxymaltose
                
             💬
 | - | - | [4]  86 86, 96, 97, 299 💬
 | 
| 515 | Ferrous sulphate | - | - | - | - | [2]  96 96, 97 💬
 | 
| 516 | FILGOTINIB | [1]  Filgotinib Filgotinib | [1]  Filgotinib 
                
                    Filgotinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [6]  46 46, 53, 96, 97, 222, 271 💬
 | 
| 517 | Film-coated tablet | - | - | - | - | [1]  97 97 💬
 | 
| 518 | FITC-Adalimumab | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 519 | Flagyl | [1]  Metronidazole Metronidazole | [1]  Metronidazole 
                
                    Metronidazole
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 520 | Flaxseed | [1]  Flax seed Flax seed | - | - | - | [2]  97 97, 299 💬
 | 
| 521 | Flaxseed lignan-enriched complex (FLC) | [1]  Flax seed Flax seed | - | - | - | [1]  97 97 💬
 | 
| 522 | Flixabi | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 523 | Fluorescein | [1]  Fluorescein Fluorescein | [1]  Fluorescein 
                
                    Fluorescein
                
             💬
 | - | - | [2]  22 22, 97 💬
 | 
| 524 | Flupentixol | [1]  Flupentixol Flupentixol | [1]  Flupentixol 
                
                    Flupentixol
                
             💬
 | [2]  DRD1 DRD1, DRD2 💬
 | [11]  Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  97 97 💬
 | 
| 525 | FMT | - | - | - | - | [2]  96 96, 97 💬
 | 
| 526 | FMT enema | - | - | - | - | [1]  97 97 💬
 | 
| 527 | FMT infusions | - | - | - | - | [1]  97 97 💬
 | 
| 528 | FMT oral | - | - | - | - | [1]  97 97 💬
 | 
| 529 | Fosfomycin | [1]  Fosfomycin Fosfomycin | [1]  Fosfomycin 
                
                    Fosfomycin
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 530 | FOSFOMYCIN DISODIUM | [1]  Fosfomycin Fosfomycin | [1]  Fosfomycin 
                
                    Fosfomycin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 531 | FP-110 | - | - | - | - | [1]  97 97 💬
 | 
| 532 | FP-CYA-050 | - | - | - | - | [1]  97 97 💬
 | 
| 533 | FP-CYA-053 | - | - | - | - | [1]  97 97 💬
 | 
| 534 | Freeze-dried black raspberry powder | [1]  Raspberry Raspberry | [1]  Raspberry 
                
                    Raspberry
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 535 | Frondanol | - | - | - | - | [1]  97 97 💬
 | 
| 536 | Fully human IgG1 monoclonal antibody specific for TL1A | - | - | - | - | [2]  96 96, 97 💬
 | 
| 537 | G1567970 | - | - | - | - | [3]  46 46, 53, 97 💬
 | 
| 538 | G321605 | - | - | - | - | [3]  85 85, 96, 97 💬
 | 
| 539 | Ganciclovir | [1]  Ganciclovir Ganciclovir | [1]  Ganciclovir 
                
                    Ganciclovir
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 540 | Gastro-resistant phosphatidylcholine granules | [1]  Lecithin Lecithin | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 541 | GB004 | - | - | - | - | [1]  97 97 💬
 | 
| 542 | GB004-HCl | - | - | - | - | [1]  97 97 💬
 | 
| 543 | GED-0301 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 544 | GED-0507-34-LEVO | [1]  GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1]  97 97 💬
 | 
| 545 | GED-0507-34-Levo 160 mg | [1]  GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1]  97 97 💬
 | 
| 546 | GED-0507-34-Levo 80 mg | [1]  GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1]  97 97 💬
 | 
| 547 | GED0507 | - | - | - | - | [1]  97 97 💬
 | 
| 548 | Gelatin | [1]  Gelatin Gelatin | [2]  Gelatin 
                
                    Gelatin
                
            , 
                
                    Donkey glue
                
             💬
 | - | - | [5]  28 28, 62, 78, 97, 269 💬
 | 
| 549 | GI-270384 | - | - | - | - | [1]  97 97 💬
 | 
| 550 | Gliolan | [1]  Aminolevulinic acid Aminolevulinic acid | [1]  Aminolevulinic acid 
                
                    Aminolevulinic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 551 | GLPG0974 | - | - | - | - | [1]  97 97 💬
 | 
| 552 | GLPG1205 | - | - | - | - | [3]  85 85, 96, 97 💬
 | 
| 553 | GLPG3970 | - | - | - | - | [3]  46 46, 53, 97 💬
 | 
| 554 | Glucose | [2]  D-glucose D-glucose, Dextrose, unspecified form | [1]  Glucose 
                
                    Glucose
                
             💬
 | - | - | [12]  2 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬
 | 
| 555 | Glutamine | [1]  L-Glutamine L-Glutamine | [1]  Glutamine 
                
                    Glutamine
                
             💬
 | - | - | [8]  87 87, 89, 96, 97, 113, 222, 245, 299 💬
 | 
| 556 | Glycyrrhiza | [1]  Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [2]  53 53, 97 💬
 | 
| 557 | Glycyrrhiza glabra | [1]  Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [1]  97 97 💬
 | 
| 558 | GLYCYRRHIZA GLABRA ROOT | [1]  Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [1]  97 97 💬
 | 
| 559 | GM-CSF, fosfomycin and metronidazole | [2]  Fosfomycin Fosfomycin, Metronidazole | [2]  Metronidazole 
                
                    Metronidazole
                
            , 
                
                    Fosfomycin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 560 | Gold | [1]  Gold Gold | - | - | - | [43]  2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬
 | 
| 561 | GOLIMUMAB | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8]  46 46, 56, 84, 96, 97, 107, 270, 271 💬
 | 
| 562 | Golimumab (GLM) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 563 | Golimumab (Optimization) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 564 | Golimumab 1 mg per kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 565 | Golimumab 100 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 97 💬
 | 
| 566 | Golimumab 2 mg per kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 567 | Golimumab 200 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 568 | Golimumab 4 mg per kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 569 | Golimumab 400 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 570 | Golimumab 50 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 97 💬
 | 
| 571 | Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 572 | Golimumab Dose 1 | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 573 | Golimumab Dose 2 | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 574 | Golimumab Liquid in prefilled syringe | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 84, 97, 107 💬
 | 
| 575 | Golimumab Liquid in Vial | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 97, 271 💬
 | 
| 576 | Golimumab Prefilled Syringe | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 577 | Golimumab treatment optimization. | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 578 | Gralise | - | - | - | - | [2]  97 97, 226 💬
 | 
| 579 | Granulated mesalamine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 580 | Grapefruit | [1]  Grapefruit Grapefruit | - | - | - | [5]  6 6, 46, 50, 83, 97 💬
 | 
| 581 | Group 1- Control Diet | - | - | - | - | [1]  97 97 💬
 | 
| 582 | Group 2- UCD Diet | - | - | - | - | [1]  97 97 💬
 | 
| 583 | GS-4875 | - | - | - | - | [1]  97 97 💬
 | 
| 584 | GS-5745 | [1]  GS-5745 GS-5745 | - | - | - | [4]  46 46, 96, 97, 299 💬
 | 
| 585 | GS-5745 IV | [1]  GS-5745 GS-5745 | - | - | - | [1]  97 97 💬
 | 
| 586 | GS-5745 SC | [1]  GS-5745 GS-5745 | - | - | - | [1]  97 97 💬
 | 
| 587 | GS-6034 | - | - | - | - | [4]  46 46, 53, 96, 97 💬
 | 
| 588 | GSK1399686 | - | - | - | - | [1]  97 97 💬
 | 
| 589 | GSK1605786 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 590 | GSK1605786A | - | - | - | - | [2]  96 96, 97 💬
 | 
| 591 | GSK2586184 400mg | - | - | - | - | [1]  97 97 💬
 | 
| 592 | GSK2831781 | - | - | - | - | [1]  97 97 💬
 | 
| 593 | GSK2831781 - Double Blind Phase | - | - | - | - | [1]  97 97 💬
 | 
| 594 | GSK2831781 - Open Label phase | - | - | - | - | [1]  97 97 💬
 | 
| 595 | GSK2982772 | - | - | - | - | [2]  46 46, 97 💬
 | 
| 596 | GSK2982772A, where A denotes the free base | - | - | - | - | [2]  46 46, 97 💬
 | 
| 597 | Guaiazulene | [1]  Guaiazulen Guaiazulen | - | - | - | [1]  97 97 💬
 | 
| 598 | Guselkum | - | - | - | - | [1]  97 97 💬
 | 
| 599 | GUSELKUMAB | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [5]  37 37, 41, 51, 96, 97 💬
 | 
| 600 | Guselkumab Dose 1 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3]  51 51, 96, 97 💬
 | 
| 601 | Guselkumab Dose 2 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3]  51 51, 96, 97 💬
 | 
| 602 | Guselkumab Dose 3 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 603 | GWP42003 | - | - | - | - | [1]  97 97 💬
 | 
| 604 | H02AB | - | - | - | - | [1]  97 97 💬
 | 
| 605 | HE3286 | [1]  HE3286 HE3286 | - | - | - | [2]  46 46, 97 💬
 | 
| 606 | Hemay007 | - | - | - | - | [1]  97 97 💬
 | 
| 607 | Hepatitis A Vaccine | [1]  Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 608 | Herbal treatment (SA100) | - | - | - | - | [1]  97 97 💬
 | 
| 609 | Hextend | [1]  Hydroxyethyl Starch Hydroxyethyl Starch | [1]  Hetastarch 
                
                    Hetastarch
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 610 | HF2 | - | - | - | - | [1]  97 97 💬
 | 
| 611 | Hgd40 | - | - | - | - | [1]  97 97 💬
 | 
| 612 | HGS1025 | - | - | - | - | [1]  97 97 💬
 | 
| 613 | High dose | - | - | - | - | [1]  97 97 💬
 | 
| 614 | High Dose Budesonide | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 615 | High Dose MT-1303 | - | - | - | - | [1]  97 97 💬
 | 
| 616 | HLADQA1*05A>G screening | - | - | - | - | [2]  96 96, 97 💬
 | 
| 617 | HM201 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 618 | HMPL-004 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 619 | HMPL-004 1800 mg/day | - | - | - | - | [1]  97 97 💬
 | 
| 620 | HMPL-004 2400 mg/day | - | - | - | - | [1]  97 97 💬
 | 
| 621 | HMPL-004 high dose | - | - | - | - | [1]  97 97 💬
 | 
| 622 | HMPL-004 low dose | - | - | - | - | [1]  97 97 💬
 | 
| 623 | HMPL004-6599 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 624 | Hulio | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 625 | HuM291 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 626 | HuM291) | - | - | - | - | [1]  97 97 💬
 | 
| 627 | Human anti-IP10 monoclonal antibody | - | - | - | - | [2]  96 96, 97 💬
 | 
| 628 | Human Anti-TNF IgG1 Monoclonal Antibody | - | - | - | - | [3]  46 46, 97, 271 💬
 | 
| 629 | Human anti-TNF-alpha monoclonal antibody | - | - | - | - | [3]  46 46, 97, 107 💬
 | 
| 630 | Human Anti-TNFalfa | - | - | - | - | [3]  46 46, 97, 271 💬
 | 
| 631 | Humanized recombinant IgG4 monoclonal antibody against CD-127 | - | - | - | - | [1]  97 97 💬
 | 
| 632 | HUMIRA | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [9]  46 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
 | 
| 633 | Humira (adalimumab original) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 634 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  56 56, 97 💬
 | 
| 635 | Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 636 | Humira 40 mg solution for injection in pre-filled syringe | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 637 | Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 638 | Humira 40 mg solution for injection in pre-filled syringes | - | - | - | - | [1]  97 97 💬
 | 
| 639 | Humira 40 mg/0.8 ml solution for injection | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 640 | Humira 40 mg/0.8 ml solution for injection for paediatric use | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 641 | HUMIRA 40Mg Solution for Injection | - | - | - | - | [2]  96 96, 97 💬
 | 
| 642 | Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 643 | HUMIRA ® | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 644 | Humira® | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5]  46 46, 96, 97, 107, 271 💬
 | 
| 645 | Hyaluronate | [1]  Hyaluronic acid Hyaluronic acid | [1]  Hyaluronic acid 
                
                    Hyaluronic acid
                
             💬
 | - | - | [2]  53 53, 97 💬
 | 
| 646 | Hydrocortisone | [2]  Hydrocortisone Hydrocortisone, Hydrocortisone acetate | [2]  Hydrocortisone 
                
                    Hydrocortisone
                
            , 
                
                    Hydrocortisone acetate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10]  6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
 | 
| 647 | HYDROCORTISONE ACETATE | [3]  Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | [2]  Hydrocortisone 
                
                    Hydrocortisone
                
            , 
                
                    Hydrocortisone acetate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 648 | HYDROCORTISONE SODIUM SUCCINATE | [1]  Hydrocortisone Hydrocortisone | [1]  Hydrocortisone 
                
                    Hydrocortisone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3]  81 81, 83, 97 💬
 | 
| 649 | Hydrogen | [1]  Hydrogen Hydrogen | - | - | - | [6]  5 5, 6, 17, 83, 97, 226 💬
 | 
| 650 | Hydroxide | [1]  Hydroxide ion Hydroxide ion | - | - | - | [5]  11 11, 46, 96, 97, 284 💬
 | 
| 651 | Hydroxocobalamin | [1]  Hydroxocobalamin Hydroxocobalamin | [1]  Hydroxocobalamin 
                
                    Hydroxocobalamin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 652 | Hydroxocobalamin with Butyrate | [2]  Butyric Acid Butyric Acid, Hydroxocobalamin | [1]  Hydroxocobalamin 
                
                    Hydroxocobalamin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 653 | Hydroxychloroquine | [1]  Hydroxychloroquine Hydroxychloroquine | [1]  Hydroxychloroquine 
                
                    Hydroxychloroquine
                
             💬
 | - | - | [27]  13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
 | 
| 654 | IBD98-M | - | - | - | - | [1]  97 97 💬
 | 
| 655 | IBD98-M Delayed-release Capsules | [1]  Manganese citrate Manganese citrate | - | - | - | [1]  97 97 💬
 | 
| 656 | Iberogast N | - | - | - | - | [1]  97 97 💬
 | 
| 657 | IBI112 | - | - | - | - | [1]  97 97 💬
 | 
| 658 | IDOFORM®Travel | - | - | - | - | [1]  97 97 💬
 | 
| 659 | IDROCORTISONE ACETATO | - | - | - | - | [1]  97 97 💬
 | 
| 660 | IL-22Fc | [1]  Efmarodocokin alfa Efmarodocokin alfa | [1]  Efmarodocokin alfa 
                
                    Efmarodocokin alfa
                
             💬
 | [1]  IL22 IL22 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2]  96 96, 97 💬
 | 
| 661 | IM90838 | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 662 | Imolope | - | - | - | - | [1]  97 97 💬
 | 
| 663 | IMU-838 | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 664 | Imuran | [1]  Azathioprine Azathioprine | [1]  Azathioprine 
                
                    Azathioprine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 665 | Imurek | - | - | - | - | [1]  97 97 💬
 | 
| 666 | Imurek 25mg Filmtabletten | - | - | - | - | [1]  97 97 💬
 | 
| 667 | Imurek 50mg Filmtabletten | - | - | - | - | [1]  97 97 💬
 | 
| 668 | IMUREL | - | - | - | - | [4]  13 13, 46, 96, 97 💬
 | 
| 669 | INCB039110 | - | - | - | - | [2]  51 51, 97 💬
 | 
| 670 | Indigo | [1]  Indigo Indigo | - | - | - | [3]  97 97, 289, 300 💬
 | 
| 671 | Infectofos | - | - | - | - | [1]  97 97 💬
 | 
| 672 | Inflectra | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 56, 96, 97 💬
 | 
| 673 | Inflectra 100 mg | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 674 | Inflectra 100 mg powder for concentrate for solution for infusion | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 675 | Infliximab | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [26]  35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬
 | 
| 676 | Infliximab (IFX) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 677 | Infliximab 10 mg/kg | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 678 | Infliximab 5 mg/kg | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 679 | Infliximab [infliximab biosimilar 3] | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  37 37, 46, 96, 97 💬
 | 
| 680 | Infliximab and adalimumab | [2]  Adalimumab Adalimumab, Infliximab | [2]  Adalimumab 
                
                    Adalimumab
                
            , 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 681 | Infliximab induction | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 682 | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab | [5]  Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5]  Adalimumab 
                
                    Adalimumab
                
            , 
                
                    Infliximab
                
            , 
                
                    Golimumab
                
            , 
                
                    Vedolizumab
                
            , 
                
                    Ustekinumab
                
             💬
 | [6]  IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬
 | [81]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 683 | Infliximab therapeutic drug monitoring | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 684 | Infliximab, adalimumab, certolizumab pegol | [3]  Adalimumab Adalimumab, Certolizumab pegol, Infliximab | [3]  Adalimumab 
                
                    Adalimumab
                
            , 
                
                    Infliximab
                
            , 
                
                    Certolizumab pegol
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 685 | Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab | [5]  Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5]  Adalimumab 
                
                    Adalimumab
                
            , 
                
                    Infliximab
                
            , 
                
                    Golimumab
                
            , 
                
                    Vedolizumab
                
            , 
                
                    Ustekinumab
                
             💬
 | [6]  IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬
 | [81]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 686 | Innovator infliximab | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 687 | Inositol | [1]  Inositol Inositol | [1]  Inositol 
                
                    Inositol
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 688 | Interferon Beta | [1]  Human interferon beta Human interferon beta | - | - | - | [6]  13 13, 20, 26, 50, 96, 97 💬
 | 
| 689 | INTERFERON BETA-1A | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [4]  13 13, 26, 96, 97 💬
 | 
| 690 | Interferon-Beta | [1]  Human interferon beta Human interferon beta | - | - | - | [2]  13 13, 97 💬
 | 
| 691 | Interferon-beta-1a | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2]  13 13, 97 💬
 | 
| 692 | Interferon-beta-1a, 44 microgram | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  97 97 💬
 | 
| 693 | Interferon-beta-1a, 66 microgram | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  97 97 💬
 | 
| 694 | INTERLEUKIN 2 | - | - | - | - | [9]  46 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
 | 
| 695 | INTERLEUKIN-2 | [1]  Human interleukin-2 Human interleukin-2 | - | - | - | [10]  2 2, 35, 49, 50, 53, 55, 65, 96, 97, 162 💬
 | 
| 696 | Interleukin-2 (aldesleukin). | [2]  Aldesleukin Aldesleukin, Human interleukin-2 | [1]  Aldesleukin 
                
                    Aldesleukin
                
             💬
 | [3]  IL2RA IL2RA, IL2RB, IL2RG 💬
 | [14]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  96 96, 97 💬
 | 
| 697 | Intestinal flora capsule | - | - | - | - | [1]  97 97 💬
 | 
| 698 | Intravenous (IV) infusions | - | - | - | - | [2]  13 13, 97 💬
 | 
| 699 | Iron | [1]  Iron Iron | - | - | - | [6]  18 18, 96, 97, 238, 254, 284 💬
 | 
| 700 | Iron sucrose | [3]  Iron Iron, Iron sucrose, Sucrose | [2]  Sucrose 
                
                    Sucrose
                
            , 
                
                    Iron sucrose
                
             💬
 | - | - | [3]  62 62, 96, 97 💬
 | 
| 701 | Iron sulphate | [1]  Iron Iron | - | - | - | [2]  96 96, 97 💬
 | 
| 702 | Iron sulphate 200mg coated tablets | [1]  Iron Iron | - | - | - | [2]  96 96, 97 💬
 | 
| 703 | Iron supplement 300-600 mg/day | [1]  Iron Iron | - | - | - | [2]  96 96, 97 💬
 | 
| 704 | Iron(III)- hydroxide dextran complex | [3]  Dextran Dextran, Hydroxide ion, Iron | [1]  Dextran 1 
                
                    Dextran 1
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 705 | Itacitinib | [1]  Itacitinib Itacitinib | [1]  Itacitinib 
                
                    Itacitinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4]  46 46, 51, 97, 228 💬
 | 
| 706 | ITACITINIB ADIPATE | [2]  Iron (III) oxide adipate Iron (III) oxide adipate, Itacitinib | [1]  Itacitinib 
                
                    Itacitinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2]  97 97, 228 💬
 | 
| 707 | IV Corticosteroid | - | - | - | - | [1]  97 97 💬
 | 
| 708 | Janus Kinase Inhibitor | - | - | - | - | [2]  46 46, 97 💬
 | 
| 709 | JNJ-54781532 150 mg once daily | - | - | - | - | [1]  97 97 💬
 | 
| 710 | JNJ-54781532 25 mg once daily | - | - | - | - | [1]  97 97 💬
 | 
| 711 | JNJ-54781532 75 mg once daily | - | - | - | - | [1]  97 97 💬
 | 
| 712 | JNJ-54781532 75 mg twice daily | - | - | - | - | [1]  97 97 💬
 | 
| 713 | JNJ-54781532-AAD-10 mg | - | - | - | - | [1]  97 97 💬
 | 
| 714 | JNJ-54781532-AAD-30 mg | - | - | - | - | [1]  97 97 💬
 | 
| 715 | JNJ-54781532-AAD-5 mg | - | - | - | - | [1]  97 97 💬
 | 
| 716 | JNJ-64841829 | - | - | - | - | [1]  97 97 💬
 | 
| 717 | JNJ-64841842 | - | - | - | - | [1]  97 97 💬
 | 
| 718 | JNJ-64841855 | - | - | - | - | [1]  97 97 💬
 | 
| 719 | JNJ-64841894 | - | - | - | - | [1]  97 97 💬
 | 
| 720 | JNJ-64841907 | - | - | - | - | [1]  97 97 💬
 | 
| 721 | JNJ-64841920 | - | - | - | - | [1]  97 97 💬
 | 
| 722 | JNJ-64841933 | - | - | - | - | [1]  97 97 💬
 | 
| 723 | JNJ-64841946 | - | - | - | - | [1]  97 97 💬
 | 
| 724 | JNJ-66525433 | - | - | - | - | [1]  97 97 💬
 | 
| 725 | JNJ-72537634 | - | - | - | - | [1]  97 97 💬
 | 
| 726 | JNJ-78934804 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 727 | K(D)PT | - | - | - | - | [1]  97 97 💬
 | 
| 728 | Kamillenblüten 3ml/10ml | - | - | - | - | [1]  97 97 💬
 | 
| 729 | Kappaproct | - | - | - | - | [1]  97 97 💬
 | 
| 730 | KBL697 | - | - | - | - | [1]  97 97 💬
 | 
| 731 | KdPT | - | - | - | - | [1]  97 97 💬
 | 
| 732 | KHK4083 | - | - | - | - | [1]  97 97 💬
 | 
| 733 | Kremezin | - | - | - | - | [2]  96 96, 97 💬
 | 
| 734 | Kremezin®, Spherical Adsorptive Carbon | [1]  Activated charcoal Activated charcoal | - | - | - | [2]  96 96, 97 💬
 | 
| 735 | KRP203 | - | - | - | - | [1]  97 97 💬
 | 
| 736 | KRP203A | - | - | - | - | [1]  97 97 💬
 | 
| 737 | Kyo-Dophilus | - | - | - | - | [1]  97 97 💬
 | 
| 738 | Kümmel 2ml/10ml | - | - | - | - | [1]  97 97 💬
 | 
| 739 | L-arginine | [2]  Arginine Arginine, L-arginine | [1]  Arginine 
                
                    Arginine
                
             💬
 | - | - | [8]  46 46, 67, 78, 96, 97, 98, 113, 299 💬
 | 
| 740 | L-Carnitine | [1]  Levocarnitine Levocarnitine | [1]  Levocarnitine 
                
                    Levocarnitine
                
             💬
 | - | - | [7]  13 13, 86, 96, 97, 265, 298, 316 💬
 | 
| 741 | L-Lysyl-D-Prolyl-L-Threonine Acetate | [2]  Acetate Acetate, Threonine | [1]  Threonine 
                
                    Threonine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 742 | L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate | [1]  Acetate Acetate | - | - | - | [1]  97 97 💬
 | 
| 743 | Lactated Ringers | - | - | - | - | [2]  96 96, 97 💬
 | 
| 744 | Lactobacillus | [1]  Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [5]  6 6, 46, 51, 97, 299 💬
 | 
| 745 | Lactobacillus casei | [1]  Lactobacillus casei Lactobacillus casei | [1]  Lactobacillus casei 
                
                    Lactobacillus casei
                
             💬
 | - | - | [3]  6 6, 97, 296 💬
 | 
| 746 | Lactobacillus casei DG | [1]  Lactobacillus casei Lactobacillus casei | [1]  Lactobacillus casei 
                
                    Lactobacillus casei
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 747 | Lactobacillus GG | [1]  Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [1]  97 97 💬
 | 
| 748 | Lactobacillus plantarum | [1]  Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [3]  6 6, 97, 156 💬
 | 
| 749 | LACTOBACILLUS REUTERI | [1]  Lactobacillus reuteri Lactobacillus reuteri | - | - | - | [2]  97 97, 299 💬
 | 
| 750 | Lactobacillus rhamnosus GG ATCC 53103 | [1]  Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [1]  97 97 💬
 | 
| 751 | Lactobacillus salivarius | [1]  Lactobacillus salivarius Lactobacillus salivarius | - | - | - | [2]  96 96, 97 💬
 | 
| 752 | Lactobacillus salivarius UCC118 | [1]  Lactobacillus salivarius Lactobacillus salivarius | - | - | - | [2]  96 96, 97 💬
 | 
| 753 | Lactobacilus acidophilus & bifidobacterium animalis/lactis | [1]  Lactobacillus acidophilus Lactobacillus acidophilus | [1]  Lactomin 
                
                    Lactomin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 754 | Lactose | [1]  Lactose Lactose | [2]  Anhydrous lactose 
                
                    Anhydrous lactose
                
            , 
                
                    Lactose
                
             💬
 | - | - | [6]  2 2, 6, 13, 97, 228, 310 💬
 | 
| 755 | Lactose in water | [2]  Lactose Lactose, Water | [3]  Water 
                
                    Water
                
            , 
                
                    Anhydrous lactose
                
            , 
                
                    Lactose
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 756 | LC51-0255 | - | - | - | - | [1]  97 97 💬
 | 
| 757 | LDP-02 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 758 | LEVOCARNITINE | [1]  Levocarnitine Levocarnitine | [1]  Levocarnitine 
                
                    Levocarnitine
                
             💬
 | - | - | [3]  3 3, 53, 97 💬
 | 
| 759 | Levocarnitine propyl hydrochloride | [1]  Levocarnitine Levocarnitine | [1]  Levocarnitine 
                
                    Levocarnitine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 760 | Linaclotide | [1]  Linaclotide Linaclotide | [1]  Linaclotide 
                
                    Linaclotide
                
             💬
 | [1]  GUCY2C GUCY2C 💬
 | [2]  Metabolic pathways Metabolic pathways, Purine metabolism 💬 | [2]  6 6, 97 💬
 | 
| 761 | LIXACOL | - | - | - | - | [1]  97 97 💬
 | 
| 762 | Loperamide | [1]  Loperamide Loperamide | [1]  Loperamide 
                
                    Loperamide
                
             💬
 | [3]  OPRD1 OPRD1, OPRK1, OPRM1 💬
 | [5]  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2]  13 13, 97 💬
 | 
| 763 | Loperamide hydrochloride | [1]  Loperamide Loperamide | [1]  Loperamide 
                
                    Loperamide
                
             💬
 | [3]  OPRD1 OPRD1, OPRK1, OPRM1 💬
 | [5]  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  97 97 💬
 | 
| 764 | Losartan | [1]  Losartan Losartan | [1]  Losartan 
                
                    Losartan
                
             💬
 | [1]  AGTR1 AGTR1 💬
 | [16]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [17]  17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
 | 
| 765 | Low dose | - | - | - | - | [1]  97 97 💬
 | 
| 766 | Low Dose Budesonide | [1]  Budesonide Budesonide | [1]  Budesonide 
                
                    Budesonide
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 767 | Low Dose MT-1303 | - | - | - | - | [1]  97 97 💬
 | 
| 768 | Low dose naltrexone | [1]  Naltrexone Naltrexone | [1]  Naltrexone 
                
                    Naltrexone
                
             💬
 | [3]  OPRD1 OPRD1, OPRK1, OPRM1 💬
 | [5]  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 769 | Low FODMAP | - | - | - | - | [1]  97 97 💬
 | 
| 770 | LT-02 | - | - | - | - | [1]  97 97 💬
 | 
| 771 | LT-02 (modified-release PC pellets) | [1]  Manganese citrate Manganese citrate | - | - | - | [1]  97 97 💬
 | 
| 772 | Lumbar puncture | - | - | - | - | [4]  13 13, 96, 97, 127 💬
 | 
| 773 | Lusvertikimab | - | - | - | - | [1]  97 97 💬
 | 
| 774 | LX1606 | - | - | - | - | [1]  97 97 💬
 | 
| 775 | LY3074828 | - | - | - | - | [3]  37 37, 96, 97 💬
 | 
| 776 | LY3471851 | - | - | - | - | [2]  49 49, 97 💬
 | 
| 777 | LYC-30937 | - | - | - | - | [1]  97 97 💬
 | 
| 778 | LYC-30937-EC | - | - | - | - | [1]  97 97 💬
 | 
| 779 | LYS006 | - | - | - | - | [1]  97 97 💬
 | 
| 780 | Lysine | [1]  Lysine Lysine | [1]  Lysine 
                
                    Lysine
                
             💬
 | - | - | [4]  13 13, 97, 228, 299 💬
 | 
| 781 | Lysine-D-Proline-Threonine | [4]  D-Proline D-Proline, Lysine, Proline, Threonine | [3]  Proline 
                
                    Proline
                
            , 
                
                    Threonine
                
            , 
                
                    Lysine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 782 | Magnesium | [1]  Magnesium Magnesium | - | - | - | [15]  6 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
 | 
| 783 | Magnesium citrate | [2]  Magnesium Magnesium, Magnesium citrate | [1]  Magnesium citrate 
                
                    Magnesium citrate
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 784 | Maltodextrin | [1]  Maltodextrin Maltodextrin | [1]  Maltodextrin 
                
                    Maltodextrin
                
             💬
 | - | - | [4]  6 6, 13, 96, 97 💬
 | 
| 785 | Maltose | [1]  Maltose Maltose | [1]  Maltose 
                
                    Maltose
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 786 | Mango | [1]  Mango Mango | - | - | - | [2]  96 96, 97 💬
 | 
| 787 | Mango polyphenolics | [1]  Mango Mango | - | - | - | [2]  96 96, 97 💬
 | 
| 788 | Mare´s milk | - | - | - | - | [2]  96 96, 97 💬
 | 
| 789 | MATRICARIA FLOWER | [1]  Chamomile Chamomile | [1]  German chamomile flower 
                
                    German chamomile flower
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 790 | MATRICARIA RECUTITA L. FLOS | - | - | - | - | [1]  97 97 💬
 | 
| 791 | Maximal oral 5ASA | - | - | - | - | [1]  97 97 💬
 | 
| 792 | MD-0901 | - | - | - | - | [1]  97 97 💬
 | 
| 793 | MDX-1100 | - | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 794 | MDX-1100 (anti-CXCL10 human monoclonal antibody) | - | - | - | - | [1]  97 97 💬
 | 
| 795 | MEDI2070 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 796 | MEDI7183 high dose | - | - | - | - | [1]  97 97 💬
 | 
| 797 | MEDI7183 low dose | - | - | - | - | [1]  97 97 💬
 | 
| 798 | MEDI7183 medium dose | - | - | - | - | [1]  97 97 💬
 | 
| 799 | Medical Cannabis | [1]  Medical Cannabis Medical Cannabis | - | - | - | [3]  6 6, 96, 97 💬
 | 
| 800 | Melatonin | [1]  Melatonin Melatonin | [1]  Melatonin 
                
                    Melatonin
                
             💬
 | [2]  MTNR1A MTNR1A, MTNR1B 💬
 | [2]  Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [12]  6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬
 | 
| 801 | MELISSAE FOLII DRY AQUEOUS EXTRACT | - | - | - | - | [1]  97 97 💬
 | 
| 802 | Melissenblätter 15ml/10ml | - | - | - | - | [1]  97 97 💬
 | 
| 803 | Melitracen | [1]  Melitracen Melitracen | [1]  Melitracen 
                
                    Melitracen
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 804 | MENTHA × PIPERITA L. FOLIUM | - | - | - | - | [1]  97 97 💬
 | 
| 805 | Mercaptopurine | [1]  Mercaptopurine Mercaptopurine | [2]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [4]  65 65, 96, 97, 164 💬
 | 
| 806 | Mercaptopurine (Puri-Nethol) | [1]  Mercaptopurine Mercaptopurine | [2]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1]  97 97 💬
 | 
| 807 | Mercaptopurine (Purinethol) | [1]  Mercaptopurine Mercaptopurine | [2]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1]  97 97 💬
 | 
| 808 | Mesalamin | - | - | - | - | [1]  97 97 💬
 | 
| 809 | Mesalamine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [4]  96 96, 97, 98, 164 💬
 | 
| 810 | Mesalamine Delayed Release Tablets 400mg | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 811 | Mesalamine Enema | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 812 | Mesalamine Granules | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 813 | Mesalamine Once-Daily | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 814 | Mesalamine Twice-Daily | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 815 | Mesalamine, 5-aminosalicylic acid [5-ASA] | [2]  Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2]  Aminosalicylic acid 
                
                    Aminosalicylic acid
                
            , 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 816 | Mesalamine, 5-ASA | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 817 | MESALAZINA | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 818 | Mesalazine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [3]  46 46, 96, 97 💬
 | 
| 819 | Mesalazine (3,600 mg) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 820 | Mesalazine (Asacol®) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 821 | Mesalazine - TID 1000 mg | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 822 | Mesalazine - TID 2x 500 mg | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 823 | Mesalazine 1000 mg gastro-resistant tablets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 824 | Mesalazine 250Mg | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 825 | Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet | [2]  Mesalazine Mesalazine, Nitazoxanide | [2]  Mesalamine 
                
                    Mesalamine
                
            , 
                
                    Nitazoxanide
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 826 | Mesalazine 4G Enema | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 827 | Mesalazine 500 mg gastro-resistant tablets (Salofa | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 828 | Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 829 | Mesalazine Enema | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 830 | Mesalazine liquid enema | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 831 | Mesalazine slow-release granules | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 832 | Mesalazine tablet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 833 | Mesalazine with hydrocortisone sodium succinate | [2]  Hydrocortisone Hydrocortisone, Mesalazine | [2]  Hydrocortisone 
                
                    Hydrocortisone
                
            , 
                
                    Mesalamine
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 834 | Mesalazinum | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 835 | MESENCHYMAL CELLS | - | - | - | - | [1]  97 97 💬
 | 
| 836 | Mesenchymal stem cells (MSCs) | - | - | - | - | [4]  13 13, 36, 96, 97 💬
 | 
| 837 | Mesenchymal Stromal Cells | [1]  Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [10]  2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 💬
 | 
| 838 | MET-2 | - | - | - | - | [1]  97 97 💬
 | 
| 839 | Metformin | [1]  Metformin Metformin | [1]  Metformin 
                
                    Metformin
                
             💬
 | [2]  PRKAA1 PRKAA1, PRKAA2 💬
 | [20]  AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [25]  2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬
 | 
| 840 | Metformin 500 mg TID Oral Tablet | [1]  Metformin Metformin | [1]  Metformin 
                
                    Metformin
                
             💬
 | [2]  PRKAA1 PRKAA1, PRKAA2 💬
 | [20]  AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 841 | Methotrexate | [1]  Methotrexate Methotrexate | [1]  Methotrexate 
                
                    Methotrexate
                
             💬
 | [2]  DHFR DHFR, DHFR2 💬
 | [5]  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38]  11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 842 | Methotrexate bellon | [1]  Methotrexate Methotrexate | [1]  Methotrexate 
                
                    Methotrexate
                
             💬
 | [2]  DHFR DHFR, DHFR2 💬
 | [5]  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1]  97 97 💬
 | 
| 843 | Methotrexate bellon 25mg/ml | [1]  Methotrexate Methotrexate | [1]  Methotrexate 
                
                    Methotrexate
                
             💬
 | [2]  DHFR DHFR, DHFR2 💬
 | [5]  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1]  97 97 💬
 | 
| 844 | METHOTREXATE DISODIUM | [1]  Methotrexate Methotrexate | [1]  Methotrexate 
                
                    Methotrexate
                
             💬
 | [2]  DHFR DHFR, DHFR2 💬
 | [5]  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [5]  46 46, 96, 97, 107, 271 💬
 | 
| 845 | Methotrexate injection | [1]  Methotrexate Methotrexate | [1]  Methotrexate 
                
                    Methotrexate
                
             💬
 | [2]  DHFR DHFR, DHFR2 💬
 | [5]  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [2]  96 96, 97 💬
 | 
| 846 | METHYLENE BLUE | [1]  Methylene blue Methylene blue | [2]  Methylene blue 
                
                    Methylene blue
                
            , 
                
                    Methylthioninium chloride hydrate
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 847 | Methylene blue 25mg tablets | [1]  Methylene blue Methylene blue | [2]  Methylene blue 
                
                    Methylene blue
                
            , 
                
                    Methylthioninium chloride hydrate
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 848 | Methylprednisolone | [1]  Methylprednisolone Methylprednisolone | [1]  Methylprednisolone 
                
                    Methylprednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46]  2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
 | 
| 849 | METHYLPREDNISOLONE SODIUM HEMISUCCINATE | [1]  Methylprednisolone Methylprednisolone | [1]  Methylprednisolone 
                
                    Methylprednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2]  13 13, 97 💬
 | 
| 850 | METOJECT | [1]  Methotrexate Methotrexate | [1]  Methotrexate 
                
                    Methotrexate
                
             💬
 | [2]  DHFR DHFR, DHFR2 💬
 | [5]  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [6]  41 41, 46, 96, 97, 107, 271 💬
 | 
| 851 | METRONIDAZOLE | [1]  Metronidazole Metronidazole | [1]  Metronidazole 
                
                    Metronidazole
                
             💬
 | - | - | [7]  46 46, 51, 63, 94, 96, 97, 291 💬
 | 
| 852 | Metronidazole capsule 50 mg | [1]  Metronidazole Metronidazole | [1]  Metronidazole 
                
                    Metronidazole
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 853 | MEZAVANT | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 854 | Mezavant 1200 mg magensaftresistente Retardtabletten | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 855 | Mezavant Gastro-resistant, prolonged release tablets | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 856 | Mezavant XL | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 857 | Mezavant XL 1200 mg gastro-resistant prolonged release tablets | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 858 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 859 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets. | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 860 | Mezavant XL 1200mg gastro-resistant, prolonged release tablets | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 861 | Mezavant XL Gastro-resistant, prolonged release tablets | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 862 | MH002 | - | - | - | - | [1]  97 97 💬
 | 
| 863 | Microbiote fécal | - | - | - | - | [1]  97 97 💬
 | 
| 864 | Midazolam | [1]  Midazolam Midazolam | [1]  Midazolam 
                
                    Midazolam
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [12]  2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬
 | 
| 865 | Mirikizumab | [1]  Mirikizumab Mirikizumab | [1]  Mirikizumab 
                
                    Mirikizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3]  37 37, 96, 97 💬
 | 
| 866 | Mirikizumab IV | [1]  Mirikizumab Mirikizumab | [1]  Mirikizumab 
                
                    Mirikizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 867 | Mirikizumab SC | [1]  Mirikizumab Mirikizumab | [1]  Mirikizumab 
                
                    Mirikizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 868 | MitoQ | - | - | - | - | [3]  6 6, 13, 97 💬
 | 
| 869 | MK-6194 | - | - | - | - | [1]  97 97 💬
 | 
| 870 | MK-8259 | - | - | - | - | [1]  97 97 💬
 | 
| 871 | MLN0002 | - | - | - | - | [3]  94 94, 96, 97 💬
 | 
| 872 | MLN0002 (Vedolizumab) | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 873 | MLN0002 SC | - | - | - | - | [2]  96 96, 97 💬
 | 
| 874 | MLN002 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 875 | MMX Mesalamine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 876 | MMX mesalamine/ mesalazine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 877 | MMX Mesalamine/Mesalazine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 878 | MMX Mesalamine/Mesalazine (High Dose) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 879 | MMX Mesalamine/Mesalazine (Low Dose) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 880 | Modified Gegen Qinlian Decoction | - | - | - | - | [1]  97 97 💬
 | 
| 881 | Modified-release phosphatidylcholine | [2]  Lecithin Lecithin, Manganese citrate | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 882 | Molgramostim | [1]  Molgramostim Molgramostim | [1]  Molgramostim 
                
                    Molgramostim
                
             💬
 | [1]  CSF2RA CSF2RA 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [3]  97 97, 229, 299 💬
 | 
| 883 | Mongersen | [1]  Mongersen Mongersen | [1]  Mongersen 
                
                    Mongersen
                
             💬
 | [1]  SMAD7 SMAD7 💬
 | [2]  Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 884 | MONOCLONAL ANTIBODY ANTI-IGG1 | - | - | - | - | [3]  37 37, 96, 97 💬
 | 
| 885 | MORF-057 | - | - | - | - | [1]  97 97 💬
 | 
| 886 | MS-20 oral solution | - | - | - | - | [1]  97 97 💬
 | 
| 887 | MSC | - | - | - | - | [6]  6 6, 51, 60, 96, 97, 271 💬
 | 
| 888 | MT-1303 | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 889 | MTX | - | - | - | - | [14]  13 13, 35, 40, 46, 49, 50, 51, 60, 84, 96, 97, 107, 162, 271 💬
 | 
| 890 | MTX 12.5 | - | - | - | - | [1]  97 97 💬
 | 
| 891 | MTX 25 | - | - | - | - | [1]  97 97 💬
 | 
| 892 | Multiple dose- Group B | - | - | - | - | [1]  97 97 💬
 | 
| 893 | Multiple dose-Group B | - | - | - | - | [1]  97 97 💬
 | 
| 894 | MultiStem | [1]  MultiStem MultiStem | - | - | - | [1]  97 97 💬
 | 
| 895 | MultiStem high dose | [1]  MultiStem MultiStem | - | - | - | [1]  97 97 💬
 | 
| 896 | MultiStem low dose | [1]  MultiStem MultiStem | - | - | - | [1]  97 97 💬
 | 
| 897 | Mycodigest supplement | - | - | - | - | [2]  96 96, 97 💬
 | 
| 898 | MYRRH | [1]  Myrrh Myrrh | [1]  Myrrh 
                
                    Myrrh
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 899 | Myrrhinil-Intest® | - | - | - | - | [1]  97 97 💬
 | 
| 900 | N.a. | - | - | - | - | [10]  3 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 💬
 | 
| 901 | N.d. | - | - | - | - | [1]  97 97 💬
 | 
| 902 | Naltrexone | [1]  Naltrexone Naltrexone | [1]  Naltrexone 
                
                    Naltrexone
                
             💬
 | [3]  OPRD1 OPRD1, OPRK1, OPRM1 💬
 | [5]  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [12]  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
 | 
| 903 | NAND (Neoandrographolide) | - | - | - | - | [1]  97 97 💬
 | 
| 904 | Nanocort | - | - | - | - | [3]  13 13, 46, 97 💬
 | 
| 905 | Nd | - | - | - | - | [6]  2 2, 6, 13, 46, 51, 97 💬
 | 
| 906 | Neomycin | [1]  Neomycin Neomycin | [1]  Neomycin 
                
                    Neomycin
                
             💬
 | - | - | [3]  96 96, 97, 296 💬
 | 
| 907 | Neoral | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [3]  60 60, 97, 222 💬
 | 
| 908 | Neoral Soft Gelatin Capsules | [2]  Cyclosporine Cyclosporine, Gelatin | [3]  Gelatin 
                
                    Gelatin
                
            , 
                
                    Cyclosporine
                
            , 
                
                    Donkey glue
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2]  97 97, 269 💬
 | 
| 909 | Niclosamide | [1]  Niclosamide Niclosamide | [1]  Niclosamide 
                
                    Niclosamide
                
             💬
 | - | - | [2]  46 46, 97 💬
 | 
| 910 | Nicolon | - | - | - | - | [1]  97 97 💬
 | 
| 911 | Nicotinamide | [1]  Nicotinamide Nicotinamide | [1]  Niacinamide 
                
                    Niacinamide
                
             💬
 | - | - | [8]  2 2, 6, 18, 49, 97, 107, 162, 191 💬
 | 
| 912 | Nicotinamide riboside | [2]  Nicotinamide Nicotinamide, Nicotinamide riboside | [1]  Niacinamide 
                
                    Niacinamide
                
             💬
 | - | - | [5]  2 2, 6, 18, 97, 191 💬
 | 
| 913 | Nicotinamide Riboside Chloride | [3]  Chloride ion Chloride ion, Nicotinamide, Nicotinamide riboside | [1]  Niacinamide 
                
                    Niacinamide
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 914 | Nitazoxanide | [1]  Nitazoxanide Nitazoxanide | [1]  Nitazoxanide 
                
                    Nitazoxanide
                
             💬
 | - | - | [3]  46 46, 96, 97 💬
 | 
| 915 | Nitazoxanide 500Mg Oral Tablet | [1]  Nitazoxanide Nitazoxanide | [1]  Nitazoxanide 
                
                    Nitazoxanide
                
             💬
 | - | - | [2]  46 46, 97 💬
 | 
| 916 | Nivolumab | [1]  Nivolumab Nivolumab | [1]  Nivolumab 
                
                    Nivolumab
                
             💬
 | [1]  PDCD1 PDCD1 💬
 | [3]  Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12]  13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
 | 
| 917 | NO | - | - | - | - | [9]  6 6, 46, 58, 62, 86, 97, 222, 299, 321 💬
 | 
| 918 | Nolpitantium Besylate | - | - | - | - | [1]  97 97 💬
 | 
| 919 | Non as of yet | - | - | - | - | [1]  97 97 💬
 | 
| 920 | None | [1]  Interleukin-1 alpha, human recombinant Interleukin-1 alpha, human recombinant | - | - | - | [20]  6 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337 💬
 | 
| 921 | None given | [1]  Interleukin-1 alpha, human recombinant Interleukin-1 alpha, human recombinant | - | - | - | [1]  97 97 💬
 | 
| 922 | Normal Saline Enema | - | - | - | - | [1]  97 97 💬
 | 
| 923 | Null | - | - | - | - | [16]  6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
 | 
| 924 | Nutrition supplement | - | - | - | - | [1]  97 97 💬
 | 
| 925 | Nutritional dietary intervention | - | - | - | - | [2]  96 96, 97 💬
 | 
| 926 | Nuvion®) | - | - | - | - | [1]  97 97 💬
 | 
| 927 | NX-13 250 mg | - | - | - | - | [1]  97 97 💬
 | 
| 928 | NX-13 250mg IR | - | - | - | - | [1]  97 97 💬
 | 
| 929 | NX-13 500mg IR | - | - | - | - | [1]  97 97 💬
 | 
| 930 | NX-13 500mg MR | - | - | - | - | [1]  97 97 💬
 | 
| 931 | Oats | [1]  Oat Oat | - | - | - | [1]  97 97 💬
 | 
| 932 | Obefazimod | - | - | - | - | [1]  97 97 💬
 | 
| 933 | Omeprazole | [1]  Omeprazole Omeprazole | [1]  Omeprazole 
                
                    Omeprazole
                
             💬
 | [2]  ATP4A ATP4A, ATP4B 💬
 | [4]  Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [14]  6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 💬
 | 
| 934 | Ondansetron | [1]  Ondansetron Ondansetron | [1]  Ondansetron 
                
                    Ondansetron
                
             💬
 | [5]  HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
 | [2]  Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | [3]  6 6, 97, 107 💬
 | 
| 935 | Ondansetron hydrochloride dihydrate | [1]  Ondansetron Ondansetron | [1]  Ondansetron 
                
                    Ondansetron
                
             💬
 | [5]  HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
 | [2]  Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | [2]  6 6, 97 💬
 | 
| 936 | Ontamalimab | [1]  Ontamalimab Ontamalimab | - | - | - | [2]  96 96, 97 💬
 | 
| 937 | OPC-6535 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 938 | OPC-6535 Tablets (drug) | - | - | - | - | [1]  97 97 💬
 | 
| 939 | OPC-6535(Tetomilast) | [1]  Tetomilast Tetomilast | - | - | - | [2]  96 96, 97 💬
 | 
| 940 | OPRX-106 | - | - | - | - | [1]  97 97 💬
 | 
| 941 | OPRX-106 (plant cells expressing TNFR-Fc) 2mg | - | - | - | - | [1]  97 97 💬
 | 
| 942 | OPRX-106 (plant cells expressing TNFR-Fc) 8mg | - | - | - | - | [1]  97 97 💬
 | 
| 943 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | [2]  Mesalazine Mesalazine, Methylprednisolone | [2]  Mesalamine 
                
                    Mesalamine
                
            , 
                
                    Methylprednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 944 | Oral corticosteroids | - | - | - | - | [5]  13 13, 46, 97, 171, 251 💬
 | 
| 945 | Oral Iron | [1]  Iron Iron | - | - | - | [2]  97 97, 254 💬
 | 
| 946 | Oral OKT3 | - | - | - | - | [1]  97 97 💬
 | 
| 947 | ORE1001 | - | - | - | - | [1]  97 97 💬
 | 
| 948 | ORENCIA | [1]  Abatacept Abatacept | [1]  Abatacept 
                
                    Abatacept
                
             💬
 | [2]  CD80 CD80, CD86 💬
 | [13]  Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [14]  44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271 💬
 | 
| 949 | Originator (legacy) drug | - | - | - | - | [4]  46 46, 96, 97, 271 💬
 | 
| 950 | OSE-127 | - | - | - | - | [2]  53 53, 97 💬
 | 
| 951 | Oseltamivir | [1]  Oseltamivir Oseltamivir | [1]  Oseltamivir 
                
                    Oseltamivir
                
             💬
 | - | - | [2]  97 97, 299 💬
 | 
| 952 | OST-122 | - | - | - | - | [1]  97 97 💬
 | 
| 953 | Other Biologic Therapies | - | - | - | - | [2]  96 96, 97 💬
 | 
| 954 | Overencapsulated Azathioprine (Imuran) 50 mg Tablet | [1]  Azathioprine Azathioprine | [1]  Azathioprine 
                
                    Azathioprine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 955 | Overencapsulated mesalazine tablets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 956 | Ozanimod | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3]  13 13, 96, 97 💬
 | 
| 957 | Ozanimod HCL | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2]  13 13, 97 💬
 | 
| 958 | Ozanimod hydrochloride | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3]  13 13, 96, 97 💬
 | 
| 959 | Palmitoleic Acid | [1]  Palmitoleic Acid Palmitoleic Acid | - | - | - | [1]  97 97 💬
 | 
| 960 | Parnaparin | [1]  Parnaparin Parnaparin | [1]  Adomiparin 
                
                    Adomiparin
                
             💬
 | [1]  SERPINC1 SERPINC1 💬
 | [1]  Complement and coagulation cascades Complement and coagulation cascades 💬 | [1]  97 97 💬
 | 
| 961 | PARNAPARIN SODIUM | [1]  Parnaparin Parnaparin | [1]  Adomiparin 
                
                    Adomiparin
                
             💬
 | [1]  SERPINC1 SERPINC1 💬
 | [1]  Complement and coagulation cascades Complement and coagulation cascades 💬 | [1]  97 97 💬
 | 
| 962 | PBF-677 | - | - | - | - | [1]  97 97 💬
 | 
| 963 | PCT (PureCell Technologies Complex) | - | - | - | - | [1]  97 97 💬
 | 
| 964 | PEG | - | - | - | - | [15]  6 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337 💬
 | 
| 965 | PEG-liposomal Prednisolone Sodium Phosphate | [2]  Phosphate ion Phosphate ion, Prednisolone | [1]  Prednisolone 
                
                    Prednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2]  13 13, 97 💬
 | 
| 966 | Pending | - | - | - | - | [6]  13 13, 19, 96, 97, 113, 302 💬
 | 
| 967 | Pentasa | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 968 | Pentasa 2g sachet prolonged release granules (95%) | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 969 | Pentasa 500 mg Retardtabletten | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 970 | Pentasa Compact 2g, granulate with prolonged release | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 971 | Pentasa Compact 4g, granulate with prolonged release | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 972 | Pentasa enema | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 973 | Pentasa prolonged release granules 2g | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 974 | PENTASA Sachet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 975 | Pentasa Sachet 1 g | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 976 | Pentasa Sachet 1g | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 977 | Pentasa Sachet 2 g | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 978 | Pentoxifylline | [1]  Pentoxifylline Pentoxifylline | [1]  Pentoxifylline 
                
                    Pentoxifylline
                
             💬
 | - | - | [12]  26 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 💬
 | 
| 979 | Pentoxifylline 400 MG | [1]  Pentoxifylline Pentoxifylline | [1]  Pentoxifylline 
                
                    Pentoxifylline
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 980 | PF 06687234 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 981 | PF-00547659 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 982 | PF-00547659 SC injection | - | - | - | - | [2]  96 96, 97 💬
 | 
| 983 | PF-05230917 | - | - | - | - | [1]  97 97 💬
 | 
| 984 | PF-05285401 | - | - | - | - | [1]  97 97 💬
 | 
| 985 | PF-06480605 | - | - | - | - | [1]  97 97 💬
 | 
| 986 | PF-06480605 100 mg/ml | - | - | - | - | [1]  97 97 💬
 | 
| 987 | PF-06651600 | [1]  PF-06651600 PF-06651600 | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 988 | PF-06651600 10 mg | [1]  PF-06651600 PF-06651600 | - | - | - | [1]  97 97 💬
 | 
| 989 | PF-06651600 50 mg | [1]  PF-06651600 PF-06651600 | - | - | - | [2]  96 96, 97 💬
 | 
| 990 | PF-06651600-15 | [1]  PF-06651600 PF-06651600 | - | - | - | [2]  96 96, 97 💬
 | 
| 991 | PF-06687234 | - | - | - | - | [1]  97 97 💬
 | 
| 992 | PF-06700841 | [1]  PF-06700841 PF-06700841 | - | - | - | [3]  49 49, 96, 97 💬
 | 
| 993 | PF-06700841 25 mg | [1]  PF-06700841 PF-06700841 | - | - | - | [2]  96 96, 97 💬
 | 
| 994 | PF-06700841 5 mg | [1]  PF-06700841 PF-06700841 | - | - | - | [3]  49 49, 96, 97 💬
 | 
| 995 | PF-06700841-15 | [1]  PF-06700841 PF-06700841 | - | - | - | [3]  49 49, 96, 97 💬
 | 
| 996 | PF-06826647 | - | - | - | - | [1]  97 97 💬
 | 
| 997 | PF-06826647 100 mg QD | - | - | - | - | [1]  97 97 💬
 | 
| 998 | PF-06826647 300 mg QD | - | - | - | - | [1]  97 97 💬
 | 
| 999 | PF-06826647 600 mg QD | - | - | - | - | [1]  97 97 💬
 | 
| 1000 | PF-07054894 | - | - | - | - | [1]  97 97 💬
 | 
| 1001 | PF-6826647 400 mg QD | - | - | - | - | [1]  97 97 💬
 | 
| 1002 | Pfefferminzblätter 1ml/10ml | - | - | - | - | [1]  97 97 💬
 | 
| 1003 | PGx-guided post-operative pain management | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1004 | Phentermine | [1]  Phentermine Phentermine | [1]  Phentermine 
                
                    Phentermine
                
             💬
 | [5]  MAOA MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4 💬
 | [16]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  97 97 💬
 | 
| 1005 | Phentermine-Topiramate | [2]  Phentermine Phentermine, Topiramate | [2]  Topiramate 
                
                    Topiramate
                
            , 
                
                    Phentermine
                
             💬
 | [41]  CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, MAOA, MAOB, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SLC6A2, SLC6A3, SLC6A4 💬
 | [63]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  97 97 💬
 | 
| 1006 | Phosphate | [1]  Phosphate ion Phosphate ion | - | - | - | [32]  2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 💬
 | 
| 1007 | Phosphatidylcholine | [1]  Lecithin Lecithin | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1008 | Photodynamic therapy with Gliolan | [1]  Aminolevulinic acid Aminolevulinic acid | [1]  Aminolevulinic acid 
                
                    Aminolevulinic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1009 | Picosulfate | [1]  Picosulfuric acid Picosulfuric acid | - | - | - | [2]  97 97, 291 💬
 | 
| 1010 | PL8177 | - | - | - | - | [1]  97 97 💬
 | 
| 1011 | Placebo | - | - | - | - | [28]  3 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
 | 
| 1012 | PN-10884A | - | - | - | - | [1]  97 97 💬
 | 
| 1013 | PN-943 | - | - | - | - | [1]  97 97 💬
 | 
| 1014 | Polaprezinc | [1]  Polaprezinc Polaprezinc | [1]  Polaprezinc 
                
                    Polaprezinc
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 1015 | Polyethylene glycol | [1]  Polyethylene glycol Polyethylene glycol | [1]  Polyethylene glycol 3350 
                
                    Polyethylene glycol 3350
                
             💬
 | - | - | [7]  6 6, 78, 96, 97, 235, 276, 299 💬
 | 
| 1016 | Polyphenon E® | - | - | - | - | [1]  97 97 💬
 | 
| 1017 | PRA023 | - | - | - | - | [3]  51 51, 96, 97 💬
 | 
| 1018 | PRA023 IV | - | - | - | - | [3]  51 51, 96, 97 💬
 | 
| 1019 | PRD5973697 | - | - | - | - | [1]  97 97 💬
 | 
| 1020 | Prebiotics | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1021 | Prednisolon | - | - | - | - | [7]  46 46, 50, 51, 66, 95, 96, 97 💬
 | 
| 1022 | Prednisolon Jenapharm | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1023 | PREDNISOLONE | [1]  Prednisolone Prednisolone | [1]  Prednisolone 
                
                    Prednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42]  3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
 | 
| 1024 | Prednisolone sodium metasulphobenzoate | [1]  Prednisolone Prednisolone | [1]  Prednisolone 
                
                    Prednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 1025 | PREDNISOLONE SODIUM PHOSPHATE | [2]  Phosphate ion Phosphate ion, Prednisolone | [1]  Prednisolone 
                
                    Prednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3]  3 3, 13, 97 💬
 | 
| 1026 | Prednisolone Tablets B.P. 5mg | [1]  Prednisolone Prednisolone | [1]  Prednisolone 
                
                    Prednisolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 1027 | Prednisone | [1]  Prednisone Prednisone | [1]  Prednisone 
                
                    Prednisone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45]  2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
 | 
| 1028 | Prefilled Syringe delivery of Golimumab | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 1029 | Previously referred to as MEDI2070 and AMG 139 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1030 | PRIM-DJ2727 | - | - | - | - | [2]  6 6, 97 💬
 | 
| 1031 | PRO145223 | - | - | - | - | [1]  97 97 💬
 | 
| 1032 | PRO145223 (RO5490261) | - | - | - | - | [1]  97 97 💬
 | 
| 1033 | Probiotic | - | - | - | - | [8]  2 2, 6, 93, 96, 97, 193, 266, 299 💬
 | 
| 1034 | Probiotic Formula Capsule | - | - | - | - | [1]  97 97 💬
 | 
| 1035 | Probiotic Mixture | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1036 | Probiotics | - | - | - | - | [5]  6 6, 94, 96, 97, 291 💬
 | 
| 1037 | Products containing aminosalicylate | - | - | - | - | [1]  97 97 💬
 | 
| 1038 | Products containing azathioprine or 6-mercaptopurine | [2]  Azathioprine Azathioprine, Mercaptopurine | [3]  Mercaptopurine 
                
                    Mercaptopurine
                
            , 
                
                    Azathioprine
                
            , 
                
                    Mercaptopurine
                
             💬
 | [1]  HPRT1 HPRT1 💬
 | [4]  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1]  97 97 💬
 | 
| 1039 | Proline | [1]  Proline Proline | [1]  Proline 
                
                    Proline
                
             💬
 | - | - | [2]  94 94, 97 💬
 | 
| 1040 | Promiten | - | - | - | - | [1]  97 97 💬
 | 
| 1041 | PROPIONYL L-CARNITINE | [1]  Levocarnitine Levocarnitine | [1]  Levocarnitine 
                
                    Levocarnitine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1042 | PROPIONYL L-CARNITINE HYDROCHLORIDE | [1]  Levocarnitine Levocarnitine | [1]  Levocarnitine 
                
                    Levocarnitine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1043 | Propionyl-L-Carnitine | [2]  Levocarnitine Levocarnitine, Levocarnitine propionate | [1]  Levocarnitine 
                
                    Levocarnitine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1044 | Propionylcarnitinhydrochlorid | - | - | - | - | [1]  97 97 💬
 | 
| 1045 | PRV-300 | - | - | - | - | [1]  97 97 💬
 | 
| 1046 | PS | - | - | - | - | [2]  90 90, 97 💬
 | 
| 1047 | PS-QD | - | - | - | - | [1]  97 97 💬
 | 
| 1048 | PS-SP | - | - | - | - | [1]  97 97 💬
 | 
| 1049 | Psyllium | [1]  Plantago seed Plantago seed | [1]  Plantago seed 
                
                    Plantago seed
                
             💬
 | - | - | [3]  6 6, 28, 97 💬
 | 
| 1050 | Psyllium husk | [1]  Plantago seed Plantago seed | [1]  Plantago seed 
                
                    Plantago seed
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1051 | Psyllium Husk Powder | [1]  Plantago seed Plantago seed | [1]  Plantago seed 
                
                    Plantago seed
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1052 | PTG-100 | - | - | - | - | [1]  97 97 💬
 | 
| 1053 | PUR 0110 | - | - | - | - | [1]  97 97 💬
 | 
| 1054 | PUR 0110 Rectal Enema | - | - | - | - | [1]  97 97 💬
 | 
| 1055 | PUR 0110 Rectal Enema 1000 mg | - | - | - | - | [1]  97 97 💬
 | 
| 1056 | PUR 0110 Rectal Enema 250 mg | - | - | - | - | [1]  97 97 💬
 | 
| 1057 | PUR 0110 Rectal Enema 500 mg | - | - | - | - | [1]  97 97 💬
 | 
| 1058 | Puri-Nethol | - | - | - | - | [3]  86 86, 96, 97 💬
 | 
| 1059 | PV | - | - | - | - | [1]  97 97 💬
 | 
| 1060 | Pyrrolidine | [1]  Pyrrolidine Pyrrolidine | - | - | - | [2]  28 28, 97 💬
 | 
| 1061 | QBECO SSI | - | - | - | - | [1]  97 97 💬
 | 
| 1062 | R-3750 | - | - | - | - | [1]  97 97 💬
 | 
| 1063 | Raspberry | [1]  Raspberry Raspberry | [1]  Raspberry 
                
                    Raspberry
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1064 | Ravagalimab | [1]  Ravagalimab Ravagalimab | [1]  Ravagalimab 
                
                    Ravagalimab
                
             💬
 | [1]  CD40 CD40 💬
 | [17]  Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | [2]  53 53, 97 💬
 | 
| 1065 | RDP58 | - | - | - | - | [1]  97 97 💬
 | 
| 1066 | Rebamipide | [1]  Rebamipide Rebamipide | [1]  Rebamipide 
                
                    Rebamipide
                
             💬
 | - | - | [4]  46 46, 53, 97, 271 💬
 | 
| 1067 | Recombinant Factor XIII (rFXIII) | [1]  Factor XIII (human) Factor XIII (human) | - | - | - | [2]  97 97, 288 💬
 | 
| 1068 | RECTABUL2mg rectal form | - | - | - | - | [1]  97 97 💬
 | 
| 1069 | Rectal dialysis | - | - | - | - | [1]  97 97 💬
 | 
| 1070 | Rectal tacrolimus | [1]  Tacrolimus Tacrolimus | [2]  Tacrolimus 
                
                    Tacrolimus
                
            , 
                
                    Tacrolimus
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  97 97 💬
 | 
| 1071 | Regular treatment | - | - | - | - | [1]  97 97 💬
 | 
| 1072 | Regulatory T cells | - | - | - | - | [2]  95 95, 97 💬
 | 
| 1073 | Release | [1]  Manganese citrate Manganese citrate | - | - | - | [12]  6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 💬
 | 
| 1074 | Remestemcel-L | [1]  Remestemcel-L Remestemcel-L | [1]  Remestemcel-L 
                
                    Remestemcel-L
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 1075 | Remicade | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [9]  40 40, 46, 49, 56, 84, 85, 96, 97, 271 💬
 | 
| 1076 | REMICADE (INFLIXIMAB) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 1077 | Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 1078 | Remicade 100 mg powder for concentrate for solution for infusion. | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 1079 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 1080 | REMSIMA | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 1081 | Remsima (CT-P13) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 1082 | Remsima (infliximab) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 1083 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 1084 | Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 1085 | Remsima and Inflectra | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 1086 | Repomol | - | - | - | - | [1]  97 97 💬
 | 
| 1087 | Resveratrol | [1]  Resveratrol Resveratrol | - | - | - | [6]  2 2, 8, 18, 89, 97, 113 💬
 | 
| 1088 | Resveratrol Supplementation | [1]  Resveratrol Resveratrol | - | - | - | [1]  97 97 💬
 | 
| 1089 | Retarded release phosphatidylcholine | [1]  Lecithin Lecithin | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1090 | Retarded Release Phosphatidylcholine (rPC) | [1]  Lecithin Lecithin | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1091 | RhIL-11 | - | - | - | - | [1]  97 97 💬
 | 
| 1092 | RhuMAb Beta7 | - | - | - | - | [1]  97 97 💬
 | 
| 1093 | RhuMAb Beta7, Anti Beta 7, PRO145223 | - | - | - | - | [1]  97 97 💬
 | 
| 1094 | RhuMAb Beta7, Anti Beta7, PRO145223 | - | - | - | - | [1]  97 97 💬
 | 
| 1095 | Riboflavin | [1]  Riboflavin Riboflavin | [1]  Riboflavin 
                
                    Riboflavin
                
             💬
 | - | - | [7]  38 38, 46, 96, 97, 162, 168, 265 💬
 | 
| 1096 | Rifaximin | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [8]  6 6, 65, 93, 96, 97, 99, 296, 299 💬
 | 
| 1097 | Risankizumab | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [4]  37 37, 96, 97, 271 💬
 | 
| 1098 | Risankizumab (Genetical Recombination) | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 1099 | Risankizumab IV | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 1100 | Risankizumab SC | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 1101 | Ritlecitinib | - | - | - | - | [1]  97 97 💬
 | 
| 1102 | Ritlecitinib 10 mg | - | - | - | - | [1]  97 97 💬
 | 
| 1103 | Ritlecitinib 5 mg | - | - | - | - | [1]  97 97 💬
 | 
| 1104 | Ritlecitinib 50 mg | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1105 | RITUXIMAB | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48]  11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
 | 
| 1106 | Rivenprost | [1]  Rivenprost Rivenprost | - | - | - | [1]  97 97 💬
 | 
| 1107 | Rivenprost (drug) | [1]  Rivenprost Rivenprost | - | - | - | [1]  97 97 💬
 | 
| 1108 | Ro 549-0261/F04 | - | - | - | - | [1]  97 97 💬
 | 
| 1109 | RO5490261 / F02 | - | - | - | - | [1]  97 97 💬
 | 
| 1110 | RO5490261/F02 | - | - | - | - | [1]  97 97 💬
 | 
| 1111 | RO5490261/F04-02 | - | - | - | - | [1]  97 97 💬
 | 
| 1112 | RO7021610 | - | - | - | - | [1]  97 97 💬
 | 
| 1113 | RO7049665 | - | - | - | - | [2]  95 95, 97 💬
 | 
| 1114 | RO7246311 | - | - | - | - | [1]  97 97 💬
 | 
| 1115 | Roflumilast | [1]  Roflumilast Roflumilast | [1]  Roflumilast 
                
                    Roflumilast
                
             💬
 | [4]  PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
 | [5]  Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [4]  84 84, 97, 206, 299 💬
 | 
| 1116 | Roflumilast 500 Ug ORAL TABLET [Daliresp] | [1]  Roflumilast Roflumilast | [1]  Roflumilast 
                
                    Roflumilast
                
             💬
 | [4]  PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
 | [5]  Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1]  97 97 💬
 | 
| 1117 | Rosiglitazone | [1]  Rosiglitazone Rosiglitazone | [1]  Rosiglitazone 
                
                    Rosiglitazone
                
             💬
 | [1]  PPARG PPARG 💬
 | [11]  AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [5]  46 46, 75, 97, 222, 265 💬
 | 
| 1118 | Rosuvastatin | [1]  Rosuvastatin Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [11]  6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
 | 
| 1119 | Rosuvastatin 10mg | [1]  Rosuvastatin Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  97 97 💬
 | 
| 1120 | ROSUVASTATIN CALCIUM | [2]  Calcium Calcium, Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [4]  49 49, 79, 97, 299 💬
 | 
| 1121 | Rosuvastatine EG | - | - | - | - | [1]  97 97 💬
 | 
| 1122 | RPC1063 | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 1123 | RTNV148B IgG | - | - | - | - | [3]  46 46, 97, 271 💬
 | 
| 1124 | Saffron | - | - | - | - | [1]  97 97 💬
 | 
| 1125 | Saffron 100 | - | - | - | - | [1]  97 97 💬
 | 
| 1126 | Saffron 50 | - | - | - | - | [1]  97 97 💬
 | 
| 1127 | Saffron supplement for IBD | - | - | - | - | [1]  97 97 💬
 | 
| 1128 | Salicylic acid | [1]  Salicylic acid Salicylic acid | [1]  Salicylic acid 
                
                    Salicylic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1129 | Saline | [1]  Sodium chloride Sodium chloride | [1]  Sodium chloride 
                
                    Sodium chloride
                
             💬
 | - | - | [10]  6 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 💬
 | 
| 1130 | Salmon | [1]  Salmon, unspecified Salmon, unspecified | - | - | - | [3]  96 96, 97, 225 💬
 | 
| 1131 | Salofalk | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 1132 | Salofalk 1000mg Granu-Stix | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1133 | Salofalk 1000mg Granu-Stix® | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1134 | Salofalk 3g gastro-resistant prolonged-release granules | [2]  Manganese citrate Manganese citrate, Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1135 | Salofalk 4g/60ml Klysma | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1136 | Salofalk Granu-Stix 500 mg | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1137 | Salofalk® 1000mg Granu-Stix® | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1138 | Salofalk® 500 mg gastro-resistant tablet | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1139 | Salofalk® 500 mg tablets | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1140 | Salofalk® 500mg | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1141 | Salofalk® 500mg Granu-Stix® | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1142 | Sandimmum | - | - | - | - | [1]  97 97 💬
 | 
| 1143 | Sandimmun | - | - | - | - | [2]  97 97, 226 💬
 | 
| 1144 | Sandimmun 50 mg/ml, infuusiokonsentraatti | - | - | - | - | [1]  97 97 💬
 | 
| 1145 | Sandimmun Neoral | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [3]  60 60, 97, 226 💬
 | 
| 1146 | SANDINUM | - | - | - | - | [1]  97 97 💬
 | 
| 1147 | SAR339658 | - | - | - | - | [2]  13 13, 97 💬
 | 
| 1148 | SAR443122 | - | - | - | - | [1]  97 97 💬
 | 
| 1149 | SB-656933 | - | - | - | - | [1]  97 97 💬
 | 
| 1150 | SB-656933 Tablets | - | - | - | - | [2]  97 97, 299 💬
 | 
| 1151 | SB012 | - | - | - | - | [1]  97 97 💬
 | 
| 1152 | SB5 | - | - | - | - | [5]  46 46, 96, 97, 107, 271 💬
 | 
| 1153 | SC12267 | [1]  SC12267 SC12267 | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 1154 | SC12267 (4SC-101) | [1]  SC12267 SC12267 | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 1155 | SCH 900050 | - | - | - | - | [1]  97 97 💬
 | 
| 1156 | Semi-vegetarian diet | - | - | - | - | [1]  97 97 💬
 | 
| 1157 | SER-287 | - | - | - | - | [1]  97 97 💬
 | 
| 1158 | SF257 C59 | - | - | - | - | [1]  97 97 💬
 | 
| 1159 | Shingrix | [1]  Varicella zoster vaccine (recombinant) Varicella zoster vaccine (recombinant) | - | - | - | [3]  46 46, 96, 97 💬
 | 
| 1160 | SHP647 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1161 | SHR0302 | - | - | - | - | [4]  46 46, 96, 97, 271 💬
 | 
| 1162 | SHR0302 Tablets | - | - | - | - | [2]  46 46, 97 💬
 | 
| 1163 | SIMPONI | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 97, 271 💬
 | 
| 1164 | Simponi (Golimumab) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 1165 | Simponi® | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 97, 271 💬
 | 
| 1166 | Simponi® (Golimumab) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 1167 | Simulect | [1]  Basiliximab Basiliximab | [1]  Basiliximab 
                
                    Basiliximab
                
             💬
 | [1]  IL2RA IL2RA 💬
 | [11]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  66 66, 97 💬
 | 
| 1168 | Single dose-group A | - | - | - | - | [1]  97 97 💬
 | 
| 1169 | Smartject Device delivery of Golimumab | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 1170 | Smoking cigarettes | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1171 | Smoking of cannabis | [1]  Medical Cannabis Medical Cannabis | - | - | - | [2]  96 96, 97 💬
 | 
| 1172 | Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate | [1]  Pyrrolidine Pyrrolidine | - | - | - | [1]  97 97 💬
 | 
| 1173 | Sodium hyaluronate | [1]  Hyaluronic acid Hyaluronic acid | [1]  Hyaluronic acid 
                
                    Hyaluronic acid
                
             💬
 | - | - | [2]  53 53, 97 💬
 | 
| 1174 | Sodium Picosulfate/Magnesium Citrate Laxative | [4]  Magnesium Magnesium, Magnesium citrate, Picosulfuric acid, Polyethylene glycol | [2]  Magnesium citrate 
                
                    Magnesium citrate
                
            , 
                
                    Polyethylene glycol 3350
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1175 | Solu-Medrol | [2]  Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate | [2]  Methylprednisolone 
                
                    Methylprednisolone
                
            , 
                
                    Methylprednisolone hemisuccinate
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7]  13 13, 49, 50, 51, 53, 97, 211 💬
 | 
| 1176 | Sotrastaurin | [1]  Sotrastaurin Sotrastaurin | [1]  Sotrastaurin 
                
                    Sotrastaurin
                
             💬
 | [4]  PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
 | [29]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  97 97 💬
 | 
| 1177 | Sotrastaurin (INN) acetate | [2]  Acetate Acetate, Sotrastaurin | [1]  Sotrastaurin 
                
                    Sotrastaurin
                
             💬
 | [4]  PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
 | [29]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  97 97 💬
 | 
| 1178 | Soybean | [1]  Soybean Soybean | - | - | - | [1]  97 97 💬
 | 
| 1179 | SOYBEAN PHOSPHATIDYLCHOLINE | [2]  Lecithin Lecithin, Soybean | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1180 | SPD476 | - | - | - | - | [1]  97 97 💬
 | 
| 1181 | SPD476 (mesalazine) | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1182 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1183 | Spesolimab | [1]  Spesolimab Spesolimab | [1]  Spesolimab 
                
                    Spesolimab
                
             💬
 | [1]  IL1RL2 IL1RL2 💬
 | [1]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [3]  37 37, 96, 97 💬
 | 
| 1184 | Spesolimab IV infusion | [1]  Spesolimab Spesolimab | [1]  Spesolimab 
                
                    Spesolimab
                
             💬
 | [1]  IL1RL2 IL1RL2 💬
 | [1]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1]  97 97 💬
 | 
| 1185 | Spesolimab SC solution for injection | [1]  Spesolimab Spesolimab | [1]  Spesolimab 
                
                    Spesolimab
                
             💬
 | [1]  IL1RL2 IL1RL2 💬
 | [1]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1]  97 97 💬
 | 
| 1186 | SPH3127 | - | - | - | - | [1]  97 97 💬
 | 
| 1187 | SPH3127 Tablets with Dose A | - | - | - | - | [1]  97 97 💬
 | 
| 1188 | SPH3127 Tablets with Dose B | - | - | - | - | [1]  97 97 💬
 | 
| 1189 | SR140333B | - | - | - | - | [1]  97 97 💬
 | 
| 1190 | SRT2104 | - | - | - | - | [1]  97 97 💬
 | 
| 1191 | ST 261 | - | - | - | - | [1]  97 97 💬
 | 
| 1192 | ST-0529 | - | - | - | - | [1]  97 97 💬
 | 
| 1193 | ST10-021 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1194 | ST261 | - | - | - | - | [1]  97 97 💬
 | 
| 1195 | Standard 2 hours-infusion | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1196 | Standard therapy | - | - | - | - | [2]  49 49, 97 💬
 | 
| 1197 | Standardized anthocyanin-rich extract | - | - | - | - | [1]  97 97 💬
 | 
| 1198 | Standardized FODMAP | - | - | - | - | [1]  97 97 💬
 | 
| 1199 | Stasis | [1]  Ferric sulfate Ferric sulfate | [1]  Ferric sulfate 
                
                    Ferric sulfate
                
             💬
 | - | - | [2]  66 66, 97 💬
 | 
| 1200 | Stelara | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6]  49 49, 56, 96, 97, 269, 271 💬
 | 
| 1201 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2]  96 96, 97 💬
 | 
| 1202 | STELARA® | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [3]  49 49, 96, 97 💬
 | 
| 1203 | Sterile saline for injection | - | - | - | - | [1]  97 97 💬
 | 
| 1204 | Steroids | - | - | - | - | [7]  46 46, 50, 51, 63, 66, 96, 97 💬
 | 
| 1205 | STNM01 | - | - | - | - | [1]  97 97 💬
 | 
| 1206 | STNM01 1.84 mg | - | - | - | - | [1]  97 97 💬
 | 
| 1207 | STW5-II | - | - | - | - | [1]  97 97 💬
 | 
| 1208 | STW5-II (Iberogast N, BAY98-7410) | - | - | - | - | [1]  97 97 💬
 | 
| 1209 | Sucrose | [1]  Sucrose Sucrose | [1]  Sucrose 
                
                    Sucrose
                
             💬
 | - | - | [3]  62 62, 96, 97 💬
 | 
| 1210 | Sucrosomial Iron | [1]  Iron Iron | - | - | - | [1]  97 97 💬
 | 
| 1211 | Sugar Extract | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1212 | Sulphsalazine, Pentasa, Asacol, Colazide, Depentum | - | - | - | - | [1]  97 97 💬
 | 
| 1213 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | [1]  97 97 💬
 | 
| 1214 | Suspension de microbiote fécal | - | - | - | - | [1]  97 97 💬
 | 
| 1215 | Synergy-1 | - | - | - | - | [1]  97 97 💬
 | 
| 1216 | Synergy1 | - | - | - | - | [1]  97 97 💬
 | 
| 1217 | Sübetaholzwurzel 1ml/10ml | - | - | - | - | [1]  97 97 💬
 | 
| 1218 | Süßholzwurzel 1ml/10ml | - | - | - | - | [1]  97 97 💬
 | 
| 1219 | TA-650 | - | - | - | - | [4]  37 37, 56, 96, 97 💬
 | 
| 1220 | TA-650 (Infliximab) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 97, 271 💬
 | 
| 1221 | Tacrolimus | [1]  Tacrolimus Tacrolimus | [2]  Tacrolimus 
                
                    Tacrolimus
                
            , 
                
                    Tacrolimus
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [34]  2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬
 | 
| 1222 | Tauroursoursodeoxycholic acid, brand name Tudcabil | - | - | - | - | [1]  97 97 💬
 | 
| 1223 | TD-1473 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1224 | TD-1473 Dose A | - | - | - | - | [1]  97 97 💬
 | 
| 1225 | TD-1473 Dose B | - | - | - | - | [1]  97 97 💬
 | 
| 1226 | TD-1473 Dose C | - | - | - | - | [1]  97 97 💬
 | 
| 1227 | TD-3504 | - | - | - | - | [1]  97 97 💬
 | 
| 1228 | Telotristat | [1]  Telotristat Telotristat | [1]  Telotristat 
                
                    Telotristat
                
             💬
 | [2]  TPH1 TPH1, TPH2 💬
 | [4]  Folate biosynthesis Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism 💬 | [1]  97 97 💬
 | 
| 1229 | Telotristat Etiprate | [1]  Telotristat Telotristat | [1]  Telotristat 
                
                    Telotristat
                
             💬
 | [2]  TPH1 TPH1, TPH2 💬
 | [4]  Folate biosynthesis Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism 💬 | [1]  97 97 💬
 | 
| 1230 | Terbinafine | [1]  Terbinafine Terbinafine | [1]  Terbinafine 
                
                    Terbinafine
                
             💬
 | - | - | [3]  96 96, 97, 271 💬
 | 
| 1231 | Tetomilast | [1]  Tetomilast Tetomilast | - | - | - | [2]  96 96, 97 💬
 | 
| 1232 | Tetracycline | [1]  Tetracycline Tetracycline | [1]  Tetracycline 
                
                    Tetracycline
                
             💬
 | - | - | [4]  13 13, 46, 53, 97 💬
 | 
| 1233 | TEV-48574 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1234 | TEV-48574 Dose Regimen A | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1235 | TEV-48574 Dose Regiment B | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1236 | Thalidomide | [1]  Thalidomide Thalidomide | [1]  Thalidomide 
                
                    Thalidomide
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [20]  2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬
 | 
| 1237 | Thalidomide Pharmion | [1]  Thalidomide Thalidomide | [1]  Thalidomide 
                
                    Thalidomide
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  85 85, 96, 97 💬
 | 
| 1238 | Threonine | [1]  Threonine Threonine | [1]  Threonine 
                
                    Threonine
                
             💬
 | - | - | [2]  86 86, 97 💬
 | 
| 1239 | THRX-139060 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1240 | Tilpisertib | - | - | - | - | [1]  97 97 💬
 | 
| 1241 | TJ301 300mg | - | - | - | - | [1]  97 97 💬
 | 
| 1242 | TJ301 600mg | - | - | - | - | [1]  97 97 💬
 | 
| 1243 | TLL018 | - | - | - | - | [1]  97 97 💬
 | 
| 1244 | TNF Inhibitor | - | - | - | - | [2]  46 46, 97 💬
 | 
| 1245 | To be confirmed | - | - | - | - | [3]  46 46, 65, 97 💬
 | 
| 1246 | To be requested | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1247 | TOFACINITIB | - | - | - | - | [1]  97 97 💬
 | 
| 1248 | Tofacitinib | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [15]  11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 1249 | Tofacitinib 10 MG [Xeljanz] | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 1250 | TOFACITINIB CITRATE | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5]  46 46, 49, 97, 107, 271 💬
 | 
| 1251 | Tofacitinib citrate (clinical trial image) | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2]  46 46, 97 💬
 | 
| 1252 | Tofacitinib citrate (Phase III formulation) | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2]  46 46, 97 💬
 | 
| 1253 | Tofacitinib citrate (Proposed commercial formulation - debossed) | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2]  46 46, 97 💬
 | 
| 1254 | Tofacitinib citrate (Proposed commercial formulation – debossed) | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2]  46 46, 97 💬
 | 
| 1255 | Tofacitinib citrate (Proposed commercialFormulation - debossed) | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 1256 | Top down treatment if patient at high risk | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1257 | TOP1288 | - | - | - | - | [1]  97 97 💬
 | 
| 1258 | TOP1288 Rectal solution | - | - | - | - | [1]  97 97 💬
 | 
| 1259 | TOPIRAMATE | [1]  Topiramate Topiramate | [1]  Topiramate 
                
                    Topiramate
                
             💬
 | [36]  CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
 | [53]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6]  6 6, 97, 140, 144, 156, 193 💬
 | 
| 1260 | TP05 | - | - | - | - | [1]  97 97 💬
 | 
| 1261 | TP05 Coating A | - | - | - | - | [1]  97 97 💬
 | 
| 1262 | TP05 Coating B | - | - | - | - | [1]  97 97 💬
 | 
| 1263 | TP05 Coating D | - | - | - | - | [1]  97 97 💬
 | 
| 1264 | TP05 Coating E | - | - | - | - | [1]  97 97 💬
 | 
| 1265 | TP05 Coating H | - | - | - | - | [1]  97 97 💬
 | 
| 1266 | TPMT genotyping | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1267 | Traditional treatments | - | - | - | - | [1]  97 97 💬
 | 
| 1268 | Tralokinumab | [1]  Tralokinumab Tralokinumab | [1]  Tralokinumab 
                
                    Tralokinumab
                
             💬
 | [1]  IL13 IL13 💬
 | [8]  Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [2]  85 85, 97 💬
 | 
| 1269 | Treatment Algorithm A | - | - | - | - | [1]  97 97 💬
 | 
| 1270 | Treatment Algorithm B | - | - | - | - | [1]  97 97 💬
 | 
| 1271 | Treatment Algorithm C | - | - | - | - | [1]  97 97 💬
 | 
| 1272 | Treatment vs control bread | - | - | - | - | [1]  97 97 💬
 | 
| 1273 | TREMFYA | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  37 37, 97 💬
 | 
| 1274 | TREMFYA® | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  37 37, 97 💬
 | 
| 1275 | Trexan | - | - | - | - | [2]  46 46, 97 💬
 | 
| 1276 | Trexan inj 25 mg/ml | - | - | - | - | [1]  97 97 💬
 | 
| 1277 | Trichuris suis eggs | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 1278 | Trichuris suis Ova | - | - | - | - | [4]  13 13, 46, 96, 97 💬
 | 
| 1279 | Trichuris suis ova (TSO) | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1280 | Tris | [1]  Tromethamine Tromethamine | [1]  Tromethamine 
                
                    Tromethamine
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 1281 | TSO | - | - | - | - | [3]  13 13, 46, 97 💬
 | 
| 1282 | TYK2 Inhibitor | - | - | - | - | [1]  97 97 💬
 | 
| 1283 | UCB4940 | - | - | - | - | [3]  46 46, 97, 271 💬
 | 
| 1284 | UCMSC group | - | - | - | - | [1]  97 97 💬
 | 
| 1285 | UDCA | [1]  Ursodeoxycholic acid Ursodeoxycholic acid | [1]  Ursodiol 
                
                    Ursodiol
                
             💬
 | [1]  NR1H4 NR1H4 💬
 | [1]  Bile secretion Bile secretion 💬 | [6]  46 46, 67, 93, 94, 97, 296 💬
 | 
| 1286 | Umbilical cord blood mononuclear cells | - | - | - | - | [1]  97 97 💬
 | 
| 1287 | Umbilical cord mesenchymal stem cells | - | - | - | - | [5]  13 13, 46, 57, 97, 113 💬
 | 
| 1288 | Unknown | - | - | - | - | [3]  34 34, 67, 97 💬
 | 
| 1289 | Upadacitinib | [1]  Upadacitinib Upadacitinib | [1]  Upadacitinib 
                
                    Upadacitinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [8]  40 40, 41, 46, 49, 96, 97, 107, 271 💬
 | 
| 1290 | Upadacitinib (ABT-494) | [1]  Upadacitinib Upadacitinib | [1]  Upadacitinib 
                
                    Upadacitinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 1291 | Upadacitinib - Direct compression-yellow | [1]  Upadacitinib Upadacitinib | [1]  Upadacitinib 
                
                    Upadacitinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 1292 | Upadacitinib -Direct compression-yellow | [1]  Upadacitinib Upadacitinib | [1]  Upadacitinib 
                
                    Upadacitinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 1293 | Updacitinib (ABT-494) | - | - | - | - | [1]  97 97 💬
 | 
| 1294 | UR-12746-S | - | - | - | - | [1]  97 97 💬
 | 
| 1295 | Urbason | - | - | - | - | [3]  13 13, 97, 222 💬
 | 
| 1296 | Ursodeoxycholic acid | [1]  Ursodeoxycholic acid Ursodeoxycholic acid | [1]  Ursodiol 
                
                    Ursodiol
                
             💬
 | [1]  NR1H4 NR1H4 💬
 | [1]  Bile secretion Bile secretion 💬 | [10]  6 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
 | 
| 1297 | Ursodiol | [1]  Ursodeoxycholic acid Ursodeoxycholic acid | [1]  Ursodiol 
                
                    Ursodiol
                
             💬
 | [1]  NR1H4 NR1H4 💬
 | [1]  Bile secretion Bile secretion 💬 | [6]  8 8, 20, 93, 97, 234, 299 💬
 | 
| 1298 | Ursodiol (ursodeoxycholic acid, UDCA) | [1]  Ursodeoxycholic acid Ursodeoxycholic acid | [1]  Ursodiol 
                
                    Ursodiol
                
             💬
 | [1]  NR1H4 NR1H4 💬
 | [1]  Bile secretion Bile secretion 💬 | [1]  97 97 💬
 | 
| 1299 | Ursofalk | [1]  Ursodeoxycholic acid Ursodeoxycholic acid | [1]  Ursodiol 
                
                    Ursodiol
                
             💬
 | [1]  NR1H4 NR1H4 💬
 | [1]  Bile secretion Bile secretion 💬 | [4]  93 93, 94, 96, 97 💬
 | 
| 1300 | Ustekinumab | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [16]  37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
 | 
| 1301 | Ustekinumab Dose Based on BSA and Body Weight | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1]  97 97 💬
 | 
| 1302 | Ustekinumab induction | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1]  97 97 💬
 | 
| 1303 | Ustekinumab IV | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2]  49 49, 97 💬
 | 
| 1304 | Ustekinumab SC | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2]  49 49, 97 💬
 | 
| 1305 | Usual current care | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1306 | UTTR1147A | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1307 | UTTR1147A, IL22-Fc, IL-22Fc | [1]  Efmarodocokin alfa Efmarodocokin alfa | [1]  Efmarodocokin alfa 
                
                    Efmarodocokin alfa
                
             💬
 | [1]  IL22 IL22 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2]  96 96, 97 💬
 | 
| 1308 | UTTR1147A/RO7021610 (Active) | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1309 | V565 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1310 | Vaccine Vivotif + Vaccine Dukoral | [6]  Recombinant Cholera Toxin B Subunit Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live, Vibrio cholerae Inaba 48 classical biotype, heat inactivated, Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, heat inactivated | - | - | - | [1]  97 97 💬
 | 
| 1311 | Vaccine Vivotif + Vaccine Dukoral + oats | [7]  Oat Oat, Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live, Vibrio cholerae Inaba 48 classical biotype, heat inactivated, Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, heat inactivated | - | - | - | [1]  97 97 💬
 | 
| 1312 | Valganciclovir | [1]  Valganciclovir Valganciclovir | [1]  Valganciclovir 
                
                    Valganciclovir
                
             💬
 | - | - | [4]  85 85, 97, 299, 331 💬
 | 
| 1313 | Vaminolac | - | - | - | - | [1]  97 97 💬
 | 
| 1314 | Vaminolac, komb. | - | - | - | - | [1]  97 97 💬
 | 
| 1315 | Vamorolone | [1]  Vamorolone Vamorolone | [1]  Vamorolone 
                
                    Vamorolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2]  97 97, 113 💬
 | 
| 1316 | Vamorolone 4% suspension for oral dosing | [1]  Vamorolone Vamorolone | [1]  Vamorolone 
                
                    Vamorolone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  97 97 💬
 | 
| 1317 | Vancomycin | [1]  Vancomycin Vancomycin | [1]  Vancomycin 
                
                    Vancomycin
                
             💬
 | - | - | [8]  13 13, 46, 70, 94, 96, 97, 296, 299 💬
 | 
| 1318 | Vancomycin Oral Capsule | [1]  Vancomycin Vancomycin | [1]  Vancomycin 
                
                    Vancomycin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1319 | Vancomycin Pre-Treat | [1]  Vancomycin Vancomycin | [1]  Vancomycin 
                
                    Vancomycin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1320 | Vancomycin Pre-Treatment | [1]  Vancomycin Vancomycin | [1]  Vancomycin 
                
                    Vancomycin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1321 | Vatelizumab | [1]  Vatelizumab Vatelizumab | - | - | - | [2]  13 13, 97 💬
 | 
| 1322 | VB-201 | [1]  VB-201 VB-201 | - | - | - | [1]  97 97 💬
 | 
| 1323 | VB-201 160mg | [1]  VB-201 VB-201 | - | - | - | [1]  97 97 💬
 | 
| 1324 | VE202 | - | - | - | - | [1]  97 97 💬
 | 
| 1325 | VEDOLIZUMAB | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3]  94 94, 96, 97 💬
 | 
| 1326 | Vedolizumab 108 mg SC | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1327 | Vedolizumab 300 mg | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1328 | Vedolizumab 300 mg IV | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1329 | Vedolizumab Injection | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1330 | Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1331 | Vedolizumab intravenous injection | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 1332 | Vedolizumab IV | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3]  94 94, 96, 97 💬
 | 
| 1333 | Vedolizumab IV, Placebo IV, Placebo SC | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1334 | Vedolizumab IV, Placebo SC | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1335 | Vedolizumab SC | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 1336 | Vedolizumab SC 108 mg | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 1337 | Vedolizumab subcutaneous injection | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 1338 | Vedolizumab, Entyvio | [1]  Vedolizumab Vedolizumab | [1]  Vedolizumab 
                
                    Vedolizumab
                
             💬
 | [2]  ITGA4 ITGA4, ITGB7 💬
 | [15]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2]  96 96, 97 💬
 | 
| 1339 | Vedolizumab, Ustekinumab, or Tofacitinib | [3]  Tofacitinib Tofacitinib, Ustekinumab, Vedolizumab | [3]  Vedolizumab 
                
                    Vedolizumab
                
            , 
                
                    Ustekinumab
                
            , 
                
                    Tofacitinib
                
             💬
 | [9]  IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TYK2 💬
 | [65]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬 | [1]  97 97 💬
 | 
| 1340 | VEDULIZUMAB | - | - | - | - | [1]  97 97 💬
 | 
| 1341 | Vidofludimus | [1]  Vidofludimus Vidofludimus | - | - | - | [5]  13 13, 46, 94, 96, 97 💬
 | 
| 1342 | VIDOFLUDIMUS CALCIUM | [2]  Calcium Calcium, Vidofludimus | - | - | - | [4]  13 13, 94, 96, 97 💬
 | 
| 1343 | Vidofludimus calcium dihydrate | [2]  Calcium Calcium, Vidofludimus | - | - | - | [1]  97 97 💬
 | 
| 1344 | Vigantol | - | - | - | - | [4]  13 13, 65, 96, 97 💬
 | 
| 1345 | Vigantol Oel | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 1346 | Vigantol Oel TM | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1347 | Visilizumab | [1]  Visilizumab Visilizumab | [1]  Visilizumab 
                
                    Visilizumab
                
             💬
 | [3]  CD3D CD3D, CD3E, CD3G 💬
 | [11]  Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2]  96 96, 97 💬
 | 
| 1348 | Visilizumab (HuM291 | [1]  Visilizumab Visilizumab | [1]  Visilizumab 
                
                    Visilizumab
                
             💬
 | [3]  CD3D CD3D, CD3E, CD3G 💬
 | [11]  Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  97 97 💬
 | 
| 1349 | Visilizumab (Nuvion) | [1]  Visilizumab Visilizumab | [1]  Visilizumab 
                
                    Visilizumab
                
             💬
 | [3]  CD3D CD3D, CD3E, CD3G 💬
 | [11]  Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  97 97 💬
 | 
| 1350 | Visilizumab (Nuvion® | [1]  Visilizumab Visilizumab | [1]  Visilizumab 
                
                    Visilizumab
                
             💬
 | [3]  CD3D CD3D, CD3E, CD3G 💬
 | [11]  Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  97 97 💬
 | 
| 1351 | Vitamin B2 | [1]  Riboflavin Riboflavin | [1]  Riboflavin 
                
                    Riboflavin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 1352 | Vitamin D | [2]  Cholecalciferol Cholecalciferol, Vitamin D | [1]  Cholecalciferol 
                
                    Cholecalciferol
                
             💬
 | [1]  VDR VDR 💬
 | [5]  Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [20]  13 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299 💬
 | 
| 1353 | Vitamin D drops | [1]  Vitamin D Vitamin D | - | - | - | [2]  96 96, 97 💬
 | 
| 1354 | Vitamin D3 | [1]  Cholecalciferol Cholecalciferol | [1]  Cholecalciferol 
                
                    Cholecalciferol
                
             💬
 | [1]  VDR VDR 💬
 | [5]  Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [12]  6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
 | 
| 1355 | Vitamin E | [1]  Vitamin E Vitamin E | [1]  Vitamin E 
                
                    Vitamin E
                
             💬
 | - | - | [11]  2 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 💬
 | 
| 1356 | Vitamin E 800IU | [1]  Vitamin E Vitamin E | [1]  Vitamin E 
                
                    Vitamin E
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 1357 | Vivotif | [1]  Typhoid Vaccine Live Typhoid Vaccine Live | - | - | - | [1]  97 97 💬
 | 
| 1358 | VSL#3 | - | - | - | - | [4]  96 96, 97, 107, 291 💬
 | 
| 1359 | VSL#3® | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1360 | VTX002 | - | - | - | - | [1]  97 97 💬
 | 
| 1361 | VTX002 is not biologic | - | - | - | - | [1]  97 97 💬
 | 
| 1362 | Water | [1]  Water Water | [1]  Water 
                
                    Water
                
             💬
 | - | - | [21]  2 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299 💬
 | 
| 1363 | Wharton Jelly Mesenchymal stem cells | - | - | - | - | [1]  97 97 💬
 | 
| 1364 | XELJANZ | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4]  46 46, 97, 107, 271 💬
 | 
| 1365 | XELJANZ - | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 1366 | XELJANZ 5 mg film-coated tablets | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2]  46 46, 97 💬
 | 
| 1367 | Xeljanz 5mg film-coated tablets | [1]  Tofacitinib Tofacitinib | [1]  Tofacitinib 
                
                    Tofacitinib
                
             💬
 | [4]  JAK1 JAK1, JAK2, JAK3, TYK2 💬
 | [37]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  97 97 💬
 | 
| 1368 | Z-206 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 1369 | ZEPOSIA® (ozanimod) | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  97 97 💬
 | 
| 1370 | Zessly | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 1371 | Zoenasa-1:4 | - | - | - | - | [1]  97 97 💬
 |